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ABSTRACT
Purpose and rationale: Deep Sternal Wound Infections (DSWI) are associated with morbidity
rates and mortality rates as high as 10% -15% as well as significantly increased hospital costs.
The purpose of this project is to decrease current rates of DSWIs in adults undergoing cardiac
surgery at a large medical institution.
Synthesis of evidence: The literature shows a strong relationship between elevated HbA1C and
DSWI. All articles reviewed for this proposal which implement a sternal vest intervention
support its use to prevent DSWI.
Practice change and implementation strategies: The strategy used to implement these
evidence-based practice interventions includes four steps. These steps include creating awareness
and interest, building knowledge and commitment, promoting action and adoption, and pursuing
integration and sustained use. The Johns Hopkins Nursing Evidence-based Practice Model is
implemented to guide this project proposal.
Evaluation: Data on DSWI rates among cardiac surgical patients will continue to be monitored
and provide data to compare to pre-implementation. Process screening indicators, evaluation
surveys, and real-time feedback will be analyzed to measure success.
Conclusions and implications for practice: Implementing an evidence-based intervention to
address DSWI is proposed. Checking a patient’s HbA1C prior to surgery and referring them to
endocrinology or their primary care provider for education if their HbA1C is above 8.0% is
already a part of a different department project; for this reason, it was not further pursued. This
DNP project’s focus is to implement a sternal support vest worn by high-risk patients as early as
post-op day 0 (once in the ICU and stabilized) for at least six weeks postoperatively to protect
and promote sternal healing, thus preventing an infection. This vest intervention will help to
reduce DSWI rates within the department.
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Project Proposal: Adult Post-Cardiac Surgery Deep Sternal Wound Infections
Problem/Issue
Introduction to The Problem/Issue
A deep sternal wound infection (DSWI), as defined by the Society of Thoracic Surgeons
([STS], 2022a), is an infection that occurs within 30 days after surgery involving deep soft
tissues of the incision and includes at least one of the following: (a) purulent drainage from the
incision, (b) spontaneous dehiscence of the incision, or (c) deliberate opening of the incision by a
surgeon and the incision is culture positive. Additionally, if the incision is not cultured, the
patient must have one of the following symptoms: (a) fever greater than 38 degrees Celsius, (b)
local pain or tenderness, or (c) an abscess or other evidence of infection that can be detected on
direct examination, during a procedure, or during imaging study. If there is a culture obtained
and it is negative, criteria are not meet for a DSWI (STS, 2022a).
Deep sternal wound infections are a grave issue in cardiac surgery. They are associated
with many negative consequences including high morbidity and mortality rates as well as a
significant impact on a hospital’s budget due to lack of reimbursement for DSWI (Al-Ebrahim &
Al-Ebrahim, 2020). The average hospital cost associated with a DSWI is $62,000, and mortality
rates from DSWI can be as high as 10% - 15% (Marzouk et al., 2019). After completing a chart
abstraction of patients with DSWI at a large academic medical hospital in northern Midwest
United States, hospital charges for patients with a DSWI were, on average, 686% greater than for
patients with a similar surgery and no DSWI. Furthermore, the one-year mortality rate of patients
with DSWI in 2020 was found to be 33%, and 10% for 2021. The Quality Committee for the
department of Cardiac Surgery had identified an increase in DSWI to 0.5% in 2020 and 2021
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from 0.3% in 2015 to 2019; the committee is looking for ways to decrease this negative outcome
trend for patients as well as the organization.
Based upon experiences and conversations with patients with DSWI in the past, the
patient, caregiver, and family also experience negative consequences related to DSWI outside of
obvious medical concerns. Patients with DWSI typically have longer hospital stays which can
lead to greater expenses for families to stay near the hospital with them if they are not local.
Sometimes, patients' stays are long enough that their caregivers cannot afford to stay in town or
take time off from work for that length of time. Patients have experienced depression, loneliness,
and anxiety due to their complications, increased hospital stay, and strain on family members.
For caregivers, longer hospital stays can lead to stress, anxiety, and burnout. Theoretically,
reducing DSWI can aid in decreasing the number of patients and families who have these
experiences.
Purpose of Project
The purpose of this project is to implement evidence-based practice interventions to
reduce the current rate of DSWI among adults undergoing cardiac surgery at a large academic
medical center in northern Midwest United States.
Preliminary Clinical Practice Question
The preliminary clinical practice question is as follows: In adults undergoing cardiac
surgery, what are the best practices for preventing deep sternal wound infections?
Evidence
Search Strategy
An initial foray into the literature surrounding DSWI prevention was conducted with the
assistance of the medical center’s library resource. Search engines used were Cumulative Index
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of Nursing and Allied Health Literature (CINHAL), MEDLINE, and Embase. Search terms
included sternotomy or sternotomies, sternal or sternum, osteotomy, incision, surgery, surgical
wound infection, wound, incision, prevention, control, prophylaxis, and reduction. Limitations
applied to search were English language and articles published within the last ten years. The
initial search identified numerous prevention measures concerning DSWI including hemoglobin
A1C (HbA1C) screening, post-op sternal vest use, vancomycin paste applied to the sternum
before closure, sternal plating, post-op daily chlorhexidine baths, post-op surgical bra use, and
intra-operative sterile glove changes. All these prevention measures were viewed as possible
interventions and were also identified at various points within clinical time in the Cardiovascular
Surgery (CVS) department.
After the prevention measures were identified from the initial literature search, an indepth search was conducted regarding each specific prevention measure to determine if the
available evidence supported its use in practice. Librarians employed at the medical center
conducted each search and shared any applicable articles/studies along with their search process.
See Table 1 for search terms, search engines used, number of hits, and PICO question to focus
the search for literature review of individual prevention measures; a PICO question was
requested by the medical center’s librarian to clarify the intent of each search. Initial article
inclusion criteria included articles written in English with a publication date of 10 years or less.
If the initial number of articles included within 10-year cutoff was low and quality articles were
found older than that date, the initial 10-year criterion was expanded if they were foundational
studies and of quality evidence; the articles for each possible intervention include two for
HbA1C, five for sternal vest use, and one involving chlorhexidine use. A subsequent exploration
of other search engines was conducted using the same keywords to check for any missed articles;
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one new article was included from this follow-up search (Tewarie et al., 2012); databases
searched include Ovid MEDLINE, Embase, PubMed, Scopus, Google Scholar, and CINHAL.
The initial and subsequent literature searches demonstrate sufficient evidence to examine all
intervention topics related to reducing DSWI rates.
Deep Sternal Wound Infection Definition
There are two main definitions of DSWI used within the literature, either the STS
definition or the CDC definition. For the data abstraction at this project’s medical center, the
STS definition is used for this proposal because the medical center reports their DSWI data
according to the STS definition. The STS (2022b) definition of DSWI contains criteria which
includes an infection occurrence within 30 days after the operative procedure, involvement of
deep soft tissues of the incision (e.g., fascia and muscle layers), and at least one of the following
conditions: purulent drainage from the deep incision or a deep incision that spontaneously
dehisces or is deliberately opened by provider with either a positive culture or not cultured (p.
399). Moreover, the patient must have at least one of the following signs or symptoms: fever
greater than 38°C, localized pain or tenderness, or an abscess or other evidence of infection
involving the deep incision that is detected on direct examination, during invasive procedure, or
by histopathologic examination or imaging test (STS, 2022b, p. 399-400). In comparison, the
Centers for Disease Prevention (CDC) does not specify the 30-day cutoff, but it has an inclusion
option of mediastinal widening on an imaging test (2022, p. 14-15).
Among articles reviewed for this proposal, the definition used may or may not have been
identified in the articles. For example, in articles related to hemoglobin HbA1C, five studies use
the STS definition of DSWI (Bardia et al., 2017; Halkos et al., 2008a; Halkos et al., 2008b; Kim
et al., 2020; Narayan et al., 2017) and two use the CDC definition (Gatti et al., 2017; Nicolini et
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al., 2018). The remainder of the HbA1C studies did not differentiate between the types of sternal
wound infections or utilized their own grading scale (Corazzari et al., 2021; Khan et al., 2019;
Van De Eynde et al., 2021). The variety in definition of DSWI could affect the applicability of
study results to the clinical problem; however, the difference between these two definitions is
minimal, and should not have a large impact on outcomes.
Preliminary Review of Evidence
Review of the evidence identified many prevention measures for DSWI. Some of the
prevention measures were already standard practice for certain CVS surgeons at the medical
center. This was verified by conversations with stakeholders and observation in outpatient,
inpatient, and surgical settings. The prevention measures that were already part of the standard of
care were not investigated further, but those that were not standard practice, or perhaps were not
occurring routinely were investigated further. These included (a) HbA1C screening prior to
surgery, (b) post-operative sternal vest use, (c) vancomycin paste applied to the sternum before
closure, (d) sternal plating closure technique, (e) post-operative daily chlorhexidine baths, (f)
post-operative surgical bra use, and (g) intra-operative sterile glove changes. To note for this
proposal, the terms “chlorhexidine” and “Hibiclensâ” are used interchangeably, but the term
“chlorhexidine” was the primary term utilized since it is a generic, non-brand term. Nonetheless,
a literature search including both terms was conducted to ensure no articles were missed due to
terminology use.
After these seven prevention measures were identified, a literature search was conducted
targeting each prevention measure as shown in Table 1. An inclusion and exclusion process was
undertaken as described in a PRISMA diagram, see Figure 1. The preliminary article inclusion
and exclusion process is shown through the seven tables within Appendix A. The included
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articles for each intervention were then briefly analyzed regarding their level of evidence,
intervention/solution, overall study outcomes, and if the article provided evidence to support the
use of the measure to prevent DSWI; this process is shown in the tables within Appendix B.
After this preliminary intervention review, those which were supported by the literature were
then further evaluated for overall evidence and effectiveness though a detailed quality review;
the complete study evaluations related to these literature-supported interventions are found in
Appendices C and D. Level of evidence for article analysis was based on the Johns Hopkins
rating scale (Dang et al., 2022). See Table 2 for a preliminary analysis summary of all the
possible intervention topics that are discussed below.
HbA1C Screening
After observing in a variety of CVS settings and conducting an initial literature search to
obtain a generalized knowledge of the subject matter, hemoglobin A1C was a topic that came up
several times. Discussion with key stakeholders revealed interest in investigating the risk that
comes along with an elevated HbA1C and how it could be mitigated. The current state of patient
evaluation prior to surgery does not include routinely checking and reviewing HbA1C. There are
two surgeons who include HbA1C in their preoperative labs, but there is no action protocol to
follow if it is elevated. Thus, this intervention was noted as an area to explore and improve upon.
Overall, the literature shows a strong relationship between elevated HbA1C and DSWI among 9
of the 12 included studies (Corazzari et al., 2021; Gatti et al., 2017; Halkos et al., 2008a; Halkos
et al., 2008b; Kim et al., 2020; Narayan et al., 2017; Nicolini et al., 2018; Ramadan et al., 2017;
Van De Eynde et al., 2021). The cumulative effect of these discoveries led to HbA1C screening
as a chosen intervention for further review of evidence.
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Post-Op Sternal Vest Use
Through observational experiences on the inpatient post-operative units, it was
discovered that elastic sternal vests are used on some patients. There is no present protocol for
this or a consistent place in the electronic health record to make note of its use, except for in a
free-text note. In further conversations with stakeholders, a recent exploration of potential use of
a post-operative sternal support vest was discussed. Existing information on this sternal support
vest was procured for review. There had been a past effort to implement this vest, but there was
disagreement over how the vests would be paid for. The project did not move forward from that
point. With the cost analysis of DSWI patients that has been completed, it was decided to move
forward given the potential cost avoidance and breadth of evidence found. The literature search
regarding post-op sternal vests resulted in all 12 included articles with varying levels of evidence
and rigor which support this practice implementation (Albert et al., 2019; Brocki et al., 2010;
Caimmi et al., 2017; Celik et al., 2011; El-Ansary et al., 2008; Gorlitzer et al., 2009; Gorlitzer et
al., 2010; Gorlitzer et al., 2013; Klement & Herrmann, 2010; Tsang et al., 2016; Tewarie et al.,
2012; Vos et al, 2018). Five of these articles also studied the Posthoraxä vest (Epple Inc.,
Vienna, Austria), which is what this project’s institution considered previously (Albert et al.,
2019; Caimmi et al., 2017; Gorlitzer et al., 2009; Gorlitzer et al., 2010; Gorlitzer et al., 2013).
Further analysis of the evidence found regarding the topic was then completed.
Vancomycin Paste to the Sternum Before Closure
Applying sternal vancomycin paste to the sternum before chest closure for all patients
was a possible intervention which was explored further. Some surgeons already perform this
intervention for all their patients, but not all follow the practice. Three of the four included
studies support the use of vancomycin paste (Kowalski et al., 2017; Lazar et al., 2014; Magro &
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Uva, 2020). However, after looking further into the literature, there is controversy surrounding
the use of the use of vancomycin paste. There are no negative outcomes reported, but the initial
Lazar et al, 2014 study that many subsequent studies reference has noted flaws/limitations; the
study design compared statistics from the four years prior to the vancomycin paste intervention
as the control group versus the six years after the vancomycin paste implementation. Though
Lazar et al, 2014 study note there were no changes in the perioperative protocols between the
two groups, there is controversy whether the statement is accurate given the time periods elapsed
when other practice changes could have been in place. Nonetheless, stakeholder support from the
CVS surgeons is another consideration. For the reason of controversial research and the need for
full stakeholder support, this intervention of intra-op sternal vancomycin paste for all CVS
patients was not included within this project and left to the discretion of the individual CVS
surgeons regarding its use.
Sternal Plating Closure Technique
Sternal plating versus the typical sternal wires for closure was an intervention
consideration due to the theoretical benefits of having a more secure sternal closure technique,
thus reducing the risk of dehiscence/separation and consequential DSWI. Five of the nine
included studies, however, demonstrate there is little to no benefit to sternal plating regarding
direct prevention of sternal wound infections (Leinberger et al., 2018; Marzouk et al., 2018;
Matsuyama et al., 2015; Peigh et al., 2017; Royse et al., 2020). Notably, these studies do not
show any negative outcomes either. Many articles assess how sternal plating affects sternal
stability and patient’s pain, but not sternal wound infections. Several also investigate the effect of
sternal plating after a patient had a DSWI, or compare closure techniques, but they do not
include sternal plating. Also noteworthy, the CVS quality chair did not think sternal plating
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would make much of a difference to prevent DSWI. Due to stakeholder input and the lack of
supportive evidence, this intervention was not considered for implementation.
Post-Op Daily Chlorhexidine Baths
Twice-a-day chlorhexidine baths were considered for intervention due to an outpatient
sternal wound infection protocol for patients at risk for an infection that listed twice-a-day
chlorhexidine baths as protocol for that patient population. This is not currently practiced on
inpatient units for inpatient and discharging patients, unless they have a central line in place;
patients are taught to clean the cardiac surgical site daily with soap and water. During a patient’s
inpatient stay, this intervention would be a low additional cost since chlorhexidine is readily
available. However, no studies were found regarding chlorhexidine bathing postoperatively, so
there is no evidence available that could support the use of chlorhexidine bathing postoperatively.
Six of the eight included studies demonstrated benefits regarding preoperative
chlorhexidine bathing (Chien et al., 2014; Falk-Brynhildsen et al., 2013; Kieser et al., 2014;
Madej et al., 2016; Yavuz et al., 2013; Zia et al., 2020). To note, two of these six studies utilized
an infection reduction bundle/protocol which included preoperative chlorhexidine bathing (Chien
et al. 2014; Kieser et al., 2014).
Given this overall information, current research only reports the effects of chlorhexidine
use preoperatively, thus a gap in research is found by not having any available published
research on the impact of postoperative chlorhexidine use to prevent DSWI. This intervention
was not considered further due to a lack of evidentiary support.
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Post-Op Surgical Bra Use
Women’s postoperative surgical bras are already in stock within the institution’s
supplies; however, according to conversations with staff, they are not routinely used. There were
only two articles found regarding surgical bras and cardiac surgery, neither directly studying
DSWI and only one just general surgical site infections (Hummel & Charlebois, 2020; Rochon et
al., 2017). This lack of evidence creates a limitation of evidentiary support and gap in literature
regarding the topic. Of the two articles found, Hummel & Charlebois, 2020 had the highest level
of evidence with a Level III rating and had only studied 20 female patients. Rochon et al., 2017
had Level V evidence, included 348 subjects, and showed lower surgical site infection risk, but
did not study DSWI. In general, however, if the Posthoraxä sternal vests is implemented, there
would be no need for use of the surgical bra.
Intra-Op Sterile Glove Changes
While observing in the CVS operating room, it was discovered that certain surgeons
change their outer sterile gloves at certain points during the operation. For example, one surgeon
would change his outer pair of sterile gloves before handling any implanting device. When
analyzing the research, there were no studies that specifically investigated sterile glove changes
in open cardiovascular surgery. However, one study (Kozon et al., 2017) investigated surgical
glove changing during implantable electronic cardiac device operations, but that is considered an
electrophysiology surgery at this institution. Search parameters were then broadened to any type
of surgery, which led to the discovery that there is no consensus on a procedure for changing
gloves that has an impact on surgical site infections. Of the thirteen articles included, ten
supported the changing of outer surgical gloves (Enz et al., 2021; Hosseini et al., 2016; Kim et
al., 2018; Kozon et al., 2017; Kobayashi et al., 2020; Narice et al., 2021; Rehman et al., 2015;
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Scrafford et al., 2018; Tlili et al., 2018; Ward et al., 2014). For these supportive studies, all had
varying parameters or findings of when to conduct the change: hourly, every 90 minutes, one
hour into the case, before closure, and before handling instruments. Though the evidence is
inconclusive, changing the outer pair of gloves is a simple intervention that does not carry any
additional risks, except for the time needed to change gloves. From the literature, double gloving
also appears to be standard practice, which is already being done at the medical center. Surgeon
stakeholder preference is another consideration if this intervention is implemented. For the
reasons of variable evidence and stakeholder considerations, this intervention was not further
considered at this time.
Gaps in Literature
There are various gaps in literature that have affected the possible implementation of
certain interventions. One main gap is the use of postoperative chlorhexidine baths compared to
the widely used generic liquid soap. There were no studies found that investigated the topic of
postoperative chlorhexidine use, only studying preoperative use. Another gap in literature
involves intra-operative glove changing effects among CVS patients, since there are no found
articles specifically studying this population. A gap in literature was also found regarding the
effect of postoperative surgical bra use since only two articles with Level III and V evidence
were found. These gaps in literature all lead to the exclusion of interventions having no evidence
to support these interventions. However, the literature search for all the other possible
intervention topics demonstrates sufficient evidence related to DSWIs that can be analyzed for
this project proposal.
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Overall Evaluation of Evidence & Effectiveness
After completing a preliminary literature review and practice analysis on all possible
interventions outlined previously, those interventions which are most viable were then analyzed
further for overall quality of evidence and effectiveness within a detailed review. Due to the
evidentiary support for a combination of a HbA1C screening protocol and use of a postoperative
sternal vest, a subsequent in-depth literature review was conducted; these two interventions were
found to aid in addressing the identified risk factors with support from the literature to reduce
DSWI. A second review of the literature was conducted pertaining to these two specific
interventions; Appendix A outlines this process on the inclusion and exclusion rationale for each
appraised study/article. A subsequent detailed analysis of the included studies/articles related to
these topics was then conducted, which are presented in Appendix C and D, respectively. The
tables used within Appendices C and D are adapted from the “Johns Hopkins Evidence-Based
Practice Model for Nursing and Healthcare Professionals: Individual Evidence Summary Tool,”
by Johns Hopkins Health System/Johns Hopkins School of Nursing (2021); copyright 2021 by
Johns Hopkins Health System/Johns Hopkins School of Nursing. After completing the detailed
analysis of all included articles, an overall synthesis and recommendation for the two selected
interventions was completed, which is presented Tables 3 and 4, respectfully. These two tables
are from the “Johns Hopkins Evidence-Based Practice Model for Nursing and Healthcare
Professionals: Synthesis and Recommendations Tool,” by Johns Hopkins Health System/Johns
Hopkins School of Nursing (2022); copyright 2022 by Johns Hopkins Health System/Johns
Hopkins School of Nursing.
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HbA1C Screening
The literature shows an overall strong relationship between elevated HbA1C and DSWI.
Except for Bardia et al., (2017), all the studies have a population of adult cardiac surgical
patients undergoing coronary artery bypass graft (Corazzari et al., 2021; Gatti et al., 2017;
Halkos et al., 2008a; Halkos et al., 2008b; Khan et al., 2019; Kim et al., 2020; Narayan et al.,
2017; Nicolini et al., 2018; Ramadan et al., 2017; Van De Eynde et al., 2021). The population
studied in Bardia et al., (2017) were adults undergoing isolated valve surgery; this may be
significant because Bardia et al., (2017) is one of two studies that did not find a significant
correlation between HbA1C and DSWI, the other being Khan et al., (2019). This finding is
notable since the abstraction of DSWI patient data at this project’s medical center suggests that
patients undergoing coronary artery bypass grafting (CABG) are at a greater risk of DSWI than
isolated valve patients.
All 11 studies are level-three evidence according to the Johns Hopkins rating scale by
Dang et al., (2022) (Bardia et al., 2017; Corazzari et al., 2021; Gatti et al., 2017; Halkos et al.,
2008a; Halkos et al., 2008b; Khan et al., 2019; Kim et al., 2020; Narayan et al., 2017; Nicolini et
al., 2018; Ramadan et al., 2017; Van De Eynde et al., 2021). All 11 studies are retrospective,
observational, or correlational, examining HbA1C levels and the outcome of DSWI. None of the
articles reviewed included an intervention of reducing HbA1C level prior to surgery. Almost all
the studies have a large sample size but were limited by the indirect nature of the effect of
HbA1C on DSWI, leading to the conclusion that this evidence is of moderate quality. There are a
variety of HbA1C levels used for comparison groups among the studies. Seven studies use a cut
point HbA1C of 7% for comparison (Corazzari et al., 2021; Halkos et al., 2008a; Halkos et al.,
2008b; Khan et al., 2019; Kim et al., 2020; Nicolini et al., 2018; & Ramadan et al., 2017). Two
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studies use 6.5% as their cut point (Bardia et al., 2017; Narayan et al., 2017). Corazzari et al.,
(2021) also used statistical calculations for a cut point of 7.5%. Two studies treated HbA1C as a
continuous variable and did not use a cut point (Gatti et al., 2017; Van De Eynde et al., 2021).
Gatti et al., (2017) suggested that although most studies used 7% as the cut point, a HbA1C level
of greater than or equal to 8.7% is associated with the highest risk of sternal wound infection. In
conclusion, given the overall support from the literature, this intervention is appropriate for
further application at the medical center to reduce current DSWI rates. Table 3 for a synthesis
and recommendation summary of the intervention literature.
Post-Op Sternal Vest Use
All 12 studies found through the literature search support the implementation of a sternal
vest (Albert et al., 2019; Brocki et al., 2010; Caimmi et al., 2017; Celik et al., 2011; El-Ansary et
al., 2008; Gorlitzer et al., 2009; Gorlitzer et al., 2010; Gorlitzer et al., 2013; Klement &
Herrmann, 2010; Tsang et al., 2016; Tewarie et al., 2012; Vos et al., 2018). Not including the
four literature reviews or one case study, five studies specifically implemented the single-use
Posthoraxä vest which is what this project’s medical center would pursue as the specific sternal
vest to use (Albert et al., 2019; Caimmi et al., 2017; Gorlitzer et al., 2009; Gorlitzer et al., 2010;
Gorlitzer et al., 2013). The other studies did not specifically note which sternal vest they utilized,
except for Tewarie et al., (2012) which implemented the Stern-E-Fix Corset (Fendel & Keuchen
GmbH, Aachen, Germany). All the studies included patients undergoing median sternotomy,
with Klement & Herrmann (2010) specifically studying CABG patients and Albert et al. (2019)
studying only patients undergoing the bilateral internal mammary artery (BIMA) grafting
technique in CABG patients. Though there were no BIMA grafting techniques found within the
medical center DSWI patient abstraction due to their increased risk in complications, the CABG
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procedure had the most frequent occurrence of DSWI within the last three years abstracted.
Another interesting finding regarding who was included for the sternal vest, Tewarie et al. (2012)
only included high risk patients received their corset intervention group. There were no
disclosures in any of the articles pertaining to sponsorship or financial incentives from any of the
sternal vest companies.
Furthermore, when it was reported, the initiation and length of recommended use for the
sternal vest varied. Of those studies which specifically included this information, the initiation
varied from within 24 hours of the operation (Gorlitzer et al., 2009; Tewarie et al., 2012) to when
all chest tubes were removed (Caimmi et al., 2017). The second day postoperatively, when also
usually out of ICU level care, is the most common initiation time (Albert et al., 2019; Gorlitzer et
al., 2010; Gorlitzer et al., 2013). To note, El-Ansary et al. (2008) compared supportive devices at
the eight-week post-op mark for those who already had sternal instability; thus, this timeframe
was not included given their study design. Regarding the length of use, the articles varied
between six weeks after discharge (Gorlitzer et al., 2010; Gorlitzer et al., 2013; Tewarie et al.,
2012) to 90 days after discharge (Caimmi et al., 2017). The other length disclosed was up to
eight weeks after discharge (Albert et al., 2019). As shown, the most common length of use was
the six weeks after discharge mark (Gorlitzer et al., 2010; Gorlitzer et al., 2013; Tewarie et al.,
2012).
The studies found a range in levels of evidence from level one through five, according to
the Johns Hopkins rating scale by Dang et al., (2022). There are seven studies which follow the
criteria to be considered level one (Caimmi et al., 2017; Celik et al., 2011; El-Ansary et al.,
2008; Gorlitzer et al., 2009; Gorlitzer et al., 2010; Gorlitzer et al., 2013; Tewarie et al., 2012), To
note, Celik et al. (2011) described two studies within one article following the level one and
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three criteria, but the specific study which implements a sternal vest as an intervention is a part
of the level one study. There is one study with level three evidence (Albert et al., 2019) and four
studies with level five evidence (Brocki et al., 2010; Klement & Herrmann, 2010; Tsang et al.,
2016; Vos et al., 2018). Of the four studies, three are literature reviews (Brocki et al., 2010;
Tsang et al., 2016; Vos et al, 2018) and one is a case study (Klement & Herrmann, 2010). Of the
seven level one studies, only three have a sample size larger than 750 patients (Gorlitzer et al.,
2010; Gorlitzer et al., 2013; Tewarie et al., 2012), with El-Ansary et al. (2018) having the least
amount by only including 15 patients. These lower sample sizes create a limitation in the ability
to support and generalize the data as well as not having much rigor present. Of the three larger
level one studies, two are multicenter studies with 1,560 (Gorlitzer et al., 2010) and 2,539
(Gorlitzer et al., 2013) patients included. These two studies provide the best support for the
sternal vest implementation due to their sample size and multicenter use, not to mention that they
utilized the Posthoraxä vest, which is what this project’s medical center would implement as
well. Thus, the overall evidence on the Posthoraxä vest is adequate for further application
evaluation at this specific medical center. See Table 4 for a synthesis and recommendation
summary of the intervention’s included literature.
Theoretical Basis
There are various theoretical models that could be applied to the problem of DSWI, but
the Johns Hopkins Nursing Evidence Based Model (JHNEBM) was chosen as the best
theoretical basis to aid in addressing this problem (Dang et al., 2022). The JHNEBM was created
to help translate best evidence into practice; the unique aspect of the JHNEMB is its
interdisciplinary design, which includes nurses’ input (Dang et al., 2022). Overall, the JHNEBM
is an 18-step linear process which utilizes a conceptual model and tools to assist in completion of
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the forementioned steps (Melnyk & Fineout-Overholt, 2019). See Figure 2 for a visual depiction
of the model’s interprofessional flowchart.
The JHNEB model fits well with the problem of DSWI because it provides a clear threepart process of identifying a practice question, appraising the evidence, and translation of the
evidence; these three parts each have their own sub-steps, 18 in total, which combined address
the overall identified problem. The model also provides resources for appraising evidence to
ensure the appropriate level of implementation is done, whether it supports intervention, piloting,
or further study. Although the JHNEB model is a linear process, if new evidence is found, it
allows for adjustment and re-working back through an earlier step (Melnyk & Fineout-Overholt,
2019). This is an important feature since new information is available every day, and the selected
model for change must be flexible to account for that fact.
The JHNEBP model provides a fitting context for this practice change because of these
previously mentioned abilities. To frame the DSWI topic within the JHNEB model, the initial
inquiry involves why the Medical Center’s DSWI rates have increased over the previous two
years. A practice question can then be formulated asking why this increase exists, even though
there may be few yearly cases, they have large consequences. An appraisal of available evidence
regarding best practices to prevent DSWI was then done to translate what research or evidence,
into practice improvements at the Midwestern Medical Center. After a reflection process, further
inquiry and learning can be completed to continue back through the model. Thus, this theoretical
basis provides a suitable means to address the DSWI problem. Further use of the JHNEBM is
conducted within the EBP Implementation Model section of this paper and evaluated within
Table 5.
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Plan for Application of the Evidence
Identification of the Problem or Issue
Selected Interventions
After an extensive evaluation of the literature and input from key stakeholders, the
selected interventions are a preoperative A1C screening guideline and postoperative sternal vest
use. The details surrounding an elevated HbA1C, appropriate care for an elevated HbA1C, and
protocol for wearing a sternal support vest are determined by evidence existing in the literature.
If there is a positive HbA1C screen above 8.0%, a subsequent referral to either their primary care
provider or endocrinologist would then be warranted as well as the possibility of delaying
surgery if able. However, this screening protocol was already as part of the CVS department’s
perioperative Enhanced Recovery After Surgery (ERAS) model which began third quarter 2022.
For this reason and continued purposes of this DNP project, the HbA1C intervention was not
pursued further. Thus, the use of the Posthoraxä sternal support vest was the focus for this DNP
project; it would be targeted for patients who only meet certain high-risk criteria according to an
evidence-based criteria developed through this project. It would be initiated as early as post-op
day 0 (day of the operation) and used for six weeks postoperatively. This timeframe was utilized
after conversations with the stakeholders in wanting to initiate the vest as early as possible, once
stabilized in the ICU, to provide maximum benefit from its use; stabilization is usually classified
as when the patient extubated and able to get out of bed for the first time. The vest would be
worn continuously until the usual weight restriction recommendation ends at 6 weeks post-op.
Revised PICO Question
After reviewing the literature, the preliminary PICO question was revised to a more
focused final PICO question and is as follows: In adults undergoing cardiac surgery, how does
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utilizing the Posthoraxä sternal support vest after surgery affect deep sternal wound infection
rates when compared to not wearing the Posthoraxä sternal support vest?
Clinical Unity/Feasibility of Potential Interventions
Feasibility and Usefulness
The clinical feasibly and usefulness of the Posthoraxä intervention have been evaluated
by members of the stakeholder group and supported for implementation. To note, the
postoperative sternal vest use was not included within the new ERAS model, but its use has had
surgeon and CVS Clinical Nurse Specialist (CNS) support in the past. The Posthoraxä device
was pursued in the fourth quarter of 2019 and into the first quarter 2020, but between the COVID
pandemic interrupting workflow and the cost per vest, the project stalled and has not been
pursued further due to cost and supply issues. The financial benefit of the Posthoraxä vest use
has been quantified through this project. The vests will pay for themselves in cost-savings for
sternal wound infections prevented. A cost-benefit analysis is presented in Table 7 and further
discussed later in this proposal.
There are adequate physical and human resources for implementation of the Posthoraxä
vest. The CNS who originally championed use of the Posthoraxä as well as the two other CVS
CNSs will be invaluable resources to utilize as a part of this project; the three CNSs have been
engaged in the project and will serve in a SuperUser role. The outpatient nurses who will fit the
vests to patients have expressed that they have time in their workflow to add on this activity.
Inpatient and outpatient CVS nurses and providers would need to be trained regarding the fitting
and use of the device, so the three CNSs on the units would be resources to facilitate this need;
the vest comes in four sizes (M, L, XL, 2XL), so adequate education on measuring, selecting,
and fitting the vest is needed. There is plenty of available meeting space to complete education
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with staff. A Posthoraxä representative would be leveraged to assist in providing product
education to the staff as well. In the research examined, the settings for implementation of the
Posthoraxä vest are similar to this project’s medical center; they were a hospital or surgery
center. The patient population was always cardiac surgical patients, but the type of cardiac
surgery varied by study. Overall, the Posthoraxä sternal vest intervention has had clinical
barriers in the past, but due to continued support and financial benefit statistics, this intervention
has been approved for a phased implementation within the department; the purpose of this
project is to lead the initial phase.
Risks and Benefits
The benefits outweigh the risks regarding the use of the Posthoraxä support vest after
cardiac surgery in high-risk patients. Criteria to determine if a patient is high risk will be
discussed in the plan for implementation. The benefits of the Posthoraxä support vest include
reduced incidence of DSWI and decreased pain after surgery (Caimmi et al., 2017). There were
no negative consequences of vest use reported in the literature. There is concern among the
stakeholders about the potential effect the vest may have on the skin integrity of the patients.
This will be monitored during implementation. Full skin assessments are done at least twice a
day at this medical center. If any issues arise, they will theoretically be discovered quickly.
Patient Preferences
Patient preferences are a major consideration, especially when the primary core value of
the medial center is “the needs of the patient come first” (Mayo Clinic, n.d.). Reducing DSWI
rates among the CVS patient population is aligned with this core value. The foremost patient
consideration is that a reduction in DSWI rates would reduce morbidity, mortality, financial
burden, and time associated with increased medical needs (Al-Ebrahim & Al-Ebrahim, 2020). A
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decreased patient financial burden through a reduction in DSWI would also be beneficial due to
the potential reduction in hospital stay associated expenses such as family hotel and food
expenses, loss of workday expenses, and travel expenses. Decreasing DSWI rates also
potentially decreases the amount of time patients and their family members dedicate to the
patients' medical needs. These needs could include follow-up appointments, IV antibiotics,
wound vac changes, and any number of other services they may require because of DSWIs. For
reference, in the past two years, patients with DSWI at this project’s institution had an average
length-of-stay of 48 days, with a range of 5 to 126 days. For comparison, a standard cardiac
surgical patient’s expected hospital stay is five to seven days. There is also emotional and
relationship strain on family members as well as caregivers due to possibly having trouble
visiting if they do not live close or if they have trouble getting an extended amount of time away
from work.
Another consideration for patient preference would involve patient adherence in use of
the vest. For example, Gorlitzer et al. (2013) saw that almost 15% of their intervention group
refused to wear the vest and another 15% did not use the vest for other reasons. A 30% patient
non-compliance rate is significant when considering a new intervention; however, all patients
undergoing cardiac surgery were considered as a part of the 2013 study, which could have
affected the non-compliance statistic. Not all patients will have had a significant number of risk
factors to support their use of the vest potentially leading to non-compliance due to a lack of
strong evidentiary support for these patients’ potential benefits from wearing the vest. If a
targeted approach was implemented and the vest was only used among the most vulnerable
patients, then compliance will likely be improved with better justification of risk. Patients would
be educated on this intervention and subsequent preventive measures in the preoperative clinic;
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the Posthoraxä company has provided an educational brochure on its benefits for patients as
well. Ultimately, the choice to wear the vest is up to the patient. Feedback on patient experience
with the vest will be sought out to determine if improvements can be made to the process.
Summary of Recommendations
The selected intervention for this project, based on the evidence and non-inclusion within
the ERAS model, is the use of a sternal support vest; it is the primary focus of this project and
has yet to be readdressed after the first quarter of 2020. The postoperative sternal vest has level
one and level five evidentiary support. After conversations with stakeholders and considering the
evidence, the vest would be initiated as early as post operative day zero (after surgery, once
stabilized in the ICU), and it would be worn up to six weeks after surgery. The medical center’s
environment is ideal for implementation, stakeholders are interested in implementation; there are
stakeholders ready to support education and data collection, there is space available for education
sessions and meetings, there are stakeholder meetings already in existence which provide a great
opportunity for information dissemination regarding this project, and stakeholders are ready for
change and already actively looking to decrease the rate of sternal wound infections. Patients
prefer to avoid postoperative complications and associated hardships. The CVS department is
active in promoting change to improve their practice and is a supportive environment to proceed
with an initial 40-vest phase-in of the Posthoraxä support vest.
EBP Implementation Model
As introduced within the “theoretical framework” section of this proposal, the Johns
Hopkins Nursing Evidence Based Model (JHNEBM) was utilized for the project. This 18-step
model has an overarching three-part process of identifying a practice question, appraising the
evidence, and translation of the evidence into practice. This EBP implementation model fits well
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for the project since it provides an easy-to-follow process, which is broken down and specifically
evaluated within Table 5. The model helps to translate best evidence into practice for clinical,
learning, and operational practice, which is why it was selected (Melnyk & Fineout-Overholt,
2019, p. 412). Various appendices from this model have been utilized for this project as well.
Participants/Practice Setting/Clinical Context
For the Posthoraxä sternal vest intervention, the participants would be patients
undergoing cardiac surgery with median sternotomy within the medical center’s CVS department
who met specific inclusion/exclusion criteria. The rationale for the more specific criteria is both
to reduce department/patient costs and to target the patients at highest risk for DSWI. For these
reasons, a patient eligibility criteria checklist was developed based on the evidence and
consultation of the department’s CNS who championed this intervention previously; see Table 6
for the developed checklist. To qualify for a Posthoraxä support vest postoperatively, the patient
must have two or more of the following criteria present: (a) diabetes diagnosis, (b) bilateral
internal mammary artery takedown surgical technique, (c) obesity (BMI of 35 or greater), (d)
female patients with large breasts (subjective or cup size D or greater), (e) osteoporosis diagnosis
or female 65+ years old, (f) active smoker, (g) COPD diagnosis, and (h) undergoing a repeat
sternotomy. This criterion scoring rubric would be completed by the preoperative outpatient
clinic nurses at each patient's preoperative nurse visit. The vest would be fitted for the patient at
that same visit as well as education completed on purpose, benefits, and use of the vest after
surgery. A company supplied brochure on the product will be given to the patient at this time as
well. If the initial phase is continued on a permanent basis, further education would be needed
regarding inpatient nursing staff for screening and fitting patients that have emergent procedures
and bypass the outpatient preoperative clinic.
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The initial proposed pilot run of this intervention would involve the first 40 patients
meeting criteria who also agree to wear the device postoperatively: 20 male and 20 female. The
CVS department does roughly 50 surgeries per week; many of these patients have several
comorbidities, so it is estimated that it will take less than one month to reach 40 patients in the
initial phase of the intervention. Approval for implied consent would be utilized in accordance
with IRB requirements and reviewed through the medical institution’s quality improvement
guidelines. The Posthoraxä company has agreed to sponsor the 40-vest phase, but the CVS
department was willing to fund the costs within their operating room charges if the company did
not; full cost analysis is outlined within the “Resources, Proposed Budget, Timeline” section of
this proposal.
Readiness for Change
Facilitators and Barriers. Recognizing potential facilitators and barriers is key to
success in implementing change since they will influence adoption of an intervention.
Leadership support from the CVS quality chair, director of cardiac surgery’s advanced practice
providers (APPs), and agreement from the CVS quality committee are all important facilitators
of these changes. The resources available within the CVS department are also a major facilitator
which comprise of an external/internal dashboard that tracks DSWIs and a “Heartbase” database
that contains 20 years of CVS patient data. Other available resources that work as facilitators for
a project within this medical facility include a health system engineer and statisticians. The
external motivator of DSWI being publicly reported is another facilitator as it creates a need to
improve current DSWI rates.
Like any project, there are barriers to consider. The main barrier is stakeholder buy-in.
Key stakeholders including cardiac surgeons, nurse practitioners, and department certified nurse
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specialists have been involved in discussions about implementation and are on board for these
changes. Another barrier to consider is the lag in reporting of DSWI given that a set amount of
post-surgical time must pass to be considered no longer at risk for DSWI. Even though this
project involves only the CVS department at this facility, the sheer size and scope of the
organization could also be a barrier. For example, education for the sternal support vest will need
to be completed with all inpatient and outpatient RNs, inpatient and outpatient APPs, those in
CNS and NES roles within the department, and CVS surgeons. There are three different CVS
units with over 300 inpatient RNs alone who would need to adopt the change. There are possibly
many people who will need to be educated on this change. Cost is another potential barrier; this
organization has financial resources, leadership support, and a cost benefit analysis to support
these changes, but getting funding can always be a challenge.
Overall, the facilitators outweigh the barriers. For continued support, it is important that
there is regular communication with CVS leadership and stakeholders to keep them involved.
Awareness of facilitators and barriers and how to leverage them both is important as
implementation moves forward.
Building the Project Team. The project team includes several key stakeholders. A major
stakeholder is the surgeon quality chair of the CVS department; as the chair, he can promote any
adoption or change through this position, which gives him authority and respect among his peers.
The director of CVS APPs, this project’s graduate student mentor, is an important part of the
team. The nurse practitioner students leading this project are also stakeholders involved with the
project’s development, implementation, and evaluation/dissemination. Other stakeholders
include CVS surgeons, inpatient RNs, outpatient clinic RNs, CVS APPs, CVS CNSs, CVS
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NESs, desk operations specialists (DOS) who help communicate with patients and set up
appointments, and patients and their caregivers.
Support from key stakeholders is very important and has already been achieved. CVS
surgeons, APPS, CNS expressed their full support of this project and are willing to assist as
needed. With their support and full access to their resources, this project to decrease DSWI rates
already has the stakeholder foundation needed.
Outcomes and Measurement Methods/Tools
Outcomes. The outcome measurements will be centered around the sternal vests’ initial
phase impact since that is the main intervention of this project. Following the SMART acronym
(specific, measurable, attainable, relevant, and timely), the proposed sternal vest intervention has
specific indicators to measure its success. Patient preferences, clinical expertise, benchmarking
data, costs, pathophysiology, chart reviews, risk data, and infection control are all measures that
will be considered for analysis. The primary outcome indicator is DSWI rates which is defined
by the STS definition and collected by CVS abstractors, but it will be hard to predict the vests
impact to this measure given the small 40 vest trail in comparison to the large number of patients
which are operated on within the institution’s CVS department. For this reason and to gain
general feedback, patient and staff evaluations will also be a primary indicator; these are
explained further in this section. Further potential secondary measures such as a control group
comparison of pain control and hospital length-of-stay are not considered at this time since the
primary indicators are the focus for this initial phase. The relevance of sternal vest use has been
previously discussed and achieved within this proposal.
Process indicators that will be measured include the percent of patients that were offered
the Posthoraxä if they met qualifications as well as patient compliance in use of the vest
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postoperatively. Regarding the preoperative nurse assessment, the screening for the vest could be
easily added to their printed checklist which all the nurses utilize within their process as well as
adding a smart phrase into their summary note. A shared online Excel tracking sheet will be
created to see how many patients screen positive, if any that screen positive refuse the vest, and
track which patients are included in the 40-vest initial phase. However, the documentation and
charting appraisal within the postoperative period could be difficult since there is not an existing
row to document that a patient is wearing a vest within the hospital’s current electronic medical
record (EMR); the only place to chart is through a comment under “miscellaneous devices.”
Adding a line for a sternal vest into the EMR may be difficult for just an initial phase period, but
if the Posthoraxä intervention is adopted permanently, this is an avenue to pursue further.
Documentation postoperatively would need to rely upon shift notes and commenting under
“medical devices” within the EMR. Regarding the timeline of data, according to the STS criteria,
30 days must pass from the day of surgery to no longer be considered a DSWI. Because of this,
the outcome indicator of DSWI rates are timely and attainable within the timeframe. The patient
and staff evaluations will also be completed at certain points up to 6 weeks after surgery.
Considering all these points, the Posthoraxä outcome indicator of DSWI abide by the SMART
criteria and are feasible within the current organizational structure.
Measurement Tools. Regarding outcome measurement tools, there are no instruments
utilized within the DSWI outcome indicator; however, data gathering of DSWI rates will be
collected and analyzed by the CVS abstraction team. EMR documentation abstraction on sternal
vest compliance may be utilized, but again, this is not a tool and is already an established
medical practice.
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As mentioned previously, patient and staff satisfaction with the vest will be measured by
survey. On the day of discharge, the 40 patients selected for the vest initial phase will be given a
five-question Likert scale survey to assess quality, effectiveness, operation, safety,
recommendation for further use at the medical facility, and any other comments (Likert, 1932).
The developed patient evaluation Likert evaluation for day-of-discharge is included as Appendix
E. This same evaluation along with a cover letter would also be mailed to them at five weeks
post-op with a pre-addressed and stamped envelope which would be completed at the
recommended 6-week end date; the Likert scale and a draft of the cover letter is included as
Appendix F. This two-step evaluation was decided upon since it is not likely all patients will
send back the 6-week completed form, so the day-of-discharge evaluation was created to
theoretically yield a high return rate.
RN satisfaction with the vest will also be measured by survey. A voluntary Likert scale
survey will be given to the inpatient RNs at the end of the initial phase to gauge their experiences
with the new device; this evaluation is included within Appendix G. The five-point Likert scale
is routinely used within surveys and provide useful means for researchers seeking information on
subjects’ attitudes (Willits et al., 2016). To utilize this scale on patients and staff, the approval
for use of implied consent under the guideline of a quality improvement project within the
institution would again be pursued.
Data Collection Process and Logistics
Data collection centers around who collects the data, the overall process, and collection
period. The data collected will be DSWI rate, percentage of patients screened appropriately for
the vest, post op day that the vest was applied for those selected to wear the vest, and survey
feedback on the satisfaction of patients and nurses on quality, effectiveness, and operation of the
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vest. See Appendix E, Appendix F, and Appendix G to review feedback forms. The DSWI
outcome is already collected by the medical center’s employed CVS department abstractors who
review patient charts for this data, along with many other indicators selected by the CVS quality
committee; they are trained to abstract according to the STS definition of DSWI. There is already
an established process followed by this team to abstract all charts with reliability. This data
abstraction is continuously in progress, as soon as a patient is discharged from the hospital, they
are added to a queue for chart review.
To collect data on the process measure of percentage of patients screened accurately for a
Posthoraxä support vest, the nurse practitioner students leading this proposal will complete chart
reviews of patients who qualified for a vest to ensure they were screened appropriately.
Screening accuracy will be determined according to the eligibility criteria described in Table 6.
A random sample of other patient charts will be reviewed to ensure that all patients are being
screened for the vest. The two DNP students will both review the first 10 charts of patients who
received the Posthoraxä intervention to ensure that data collection on accuracy of screening of
patients for the vest is reliable. As soon as the Posthoraxä intervention is implemented data
collection regarding proper screening will start and commence once the initial phase of 40 vests
are all utilized. This period is uncertain since it depends on how long it takes the 40 vests to be
utilized, but it is estimated that it should be less than a month, given the high caseload and
comorbidities within this medical center’s CVS patient population. A confidential, password
protected shared Excel document within the CVS SharePoint database will be utilized to track
and monitor this intervention. The list of all CVS patients in the initial phase period will be
provided by the APP DNP mentor who works in the CVS preoperative clinic to the DNP
students through e-mail. This patient-confidential information will only be shared and accessed
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by the CVS quality committee members with access to the SharePoint database and the two DNP
students. Moreover, the already obtained approval memo received from the institution’s IRB
Wizard is included within Appendix H. An additional submission to the Winona State University
IRB will be completed after the conclusion of the upcoming proposal meeting.
Informal data collection will also occur. Once the trail goes live, the ICU CVS CNS will
round on the inpatient units daily during the middle of the week and in the outpatient clinic
during the first week to gain feedback and answer questions; the two DNP students will also
round these units when able around their work schedules. Rounding will be done to check in
with staff, see if they have any feedback or questions to be addresses, and to assess if they know
their resources should they have any additional questions about the vest. The information learned
from this informal rounding will be logged in a secure, password protected document on the
CVS SharePoint site. The students will note feedback received and the date it was received so if
there are any themes in feedback, they can be discussed with a larger stakeholder group and
addressed.
Plan for Data Analysis
DSWI Rates. Data preparation and analysis are two areas that can be assisted through the
medical institution’s resources. All outcome data collected from this proposal will be
quantitative. The outcome of number of patients with DSWI will be quantified as a percentage to
easily compare to previous years rates of infections and this year’s post-ERAS control group;
since the ERAS go-live will be prior to the Posthoraxä initial phase within the third quarter,
there will be sufficient data to be able to make a control period when the Posthoraxä is not being
utilized yet. The percentage of patients with DSWI will be quantified by the number of patients
who undergo median sternotomy in cardiac surgery and end up with a DSWI divided by the total
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number of patients who undergo planned median sternotomy in cardiac surgery during that same
time frame; this comparison may be hard to make given that it is a initial phase of only 40 vests,
but the comparison will still be made to see what results. The process outcome of correct
screening for vest use will also be described using a percentage or fraction. This percentage will
be calculated by the number of patients correctly screeded for a vest divided by the number of
patients that should be screened for a vest which is all patients undergoing planned median
sternotomy in cardiac surgery.
Likert Surveys. The patient and staff Likert survey data will also be tabulated and
assessed. Return rates among the patient day-of-discharge and 6-week evaluations will be
completed; the end date of survey acceptance is 3 weeks after the last survey is mailed out before
survey analysis would begin. The percentage will be calculated by the number of each evaluation
returned divided by the total amount of surveys given, i.e., 40. There will not be a paired
comparison between this two-step analysis, so no numbering of patients to compare their surveys
is needed. The 5-point Likert scale for both the patients and staff offers the ability to quantitively
examine data regarding the entire evaluation, each section, or each question through its 1-5
numerical rating; dividing the total scored by the total possible. The Yes/No recommendations at
the bottom of evaluations will also be tallied for comparison. Furthermore, the forms also
provide qualitative data from any comments left on the bottom of the form; these comments will
be added to the real-time comments collected during the go-live portion of the initial phase.
Logistics. The CVS abstractors will continue to collect data on DSWI and report this to
the other proposal stakeholders. The DNP students will collect data on process outcomes in a
shared spreadsheet within a confidential, password protected CVS SharePoint database. The two
DNP students will both review data on the first ten patients to ensure there are no mistakes or
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differences in the data they are finding. There is also a systems engineer who is working within
the CVS department on process improvements who is available to help with statistical
calculations for the project and any other facilitating needs. Reporting and discussions with the
CVS quality committee will also be conducted to best address this issue from a topic and data
analysis standpoint.
Resources, Proposed Budget, Timeline
Resources. There are several resources available for this project. The DNP students have
access to the EMR database to gather data on patients undergoing cardiac surgery. They also
have access to a shared CVS database that houses many already established data collection
metrics. There are employed CVS abstractors who are already collecting DSWI data. There is a
health system engineer who has offered to help with basic statistics, but if more complex
statistics are needed, there is a CVS statistician who can be readily able to help. However, there
is one major deficiency is that there is not currently a place for inpatient nurses, a location to
chart that a patient is wearing a sternal vest. There are currently options for where nurses could
free text in the chart, but a built-in row with an option to select sternal vest would be best. The
DNP students can reach out to the informatics team to inquire about adding a row to chart that a
sternal vest is in use, but since this is currently just an initial phase, there are no guarantees it
would be adopted. Another place where vest use could be tracked is in nursing shift notes.
Proposed Budget. Another resource to consider is funding from the
Posthoraxä company for a initial phase of 40 vests; 20 male and 20 female vests will be
provided and paid for by the Posthoraxä company. Team members' time is the other important
resource due to the already short-staffing and busy schedules of all stakeholders; time for
meetings, planning, and education is all needed to provide the best possible comparison to
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previous practices. Since this DSWI topic already on the minds of key stakeholders, there should
be little push-back on these activities; it will be just a matter of scheduling time to complete the
needed tasks. The two DNP students will also be providing their time free of charge to help
facilitate any needed activities or education through gifts of kind via time; if experienced
members of the institution were to complete the tasks of the two DNP students, including the
time to review literature and develop this project, it is estimated that it would cost the medical
institution at least $20,000 for roughly 360 hours of combined work. This project also includes
the CNS and NES staff responsibilities, but since educating and implementing EBP is considered
part of their already assigned roles, no charges are calculated for their time within the
Posthoraxä cost analysis. If the CNS and NES staff were to calculate their costs dedicated to this
project, the roughly 40 combined hours would cost the medial institution $2,200. The
Posthoraxä representative will be providing initial education to targeted staff members, free of
charge. Posthoraxä is also sponsoring a 40-vest initial phase, which would cost the company
and save the medical institution roughly $9,000. A complete budget table and in-depth costbenefit analysis can be seen in Table 7. As shown in the table, the vest cost for men is $185 or
$268 for women with breasts B-cup or larger. Through the abstraction of 2019 and 2020 patients
with DSWI, on average, the cost for a patient who had a sternal wound infection was
significantly greater when compared to patients with similar surgeries who did not contract a
DSWI. In comparison, a large number of vests could be purchased with the savings from one
prevented sternal wound infection, assuming costs associated with 50% male patients and 50%
female; a staggering amount when you also consider the secondary patient outcomes and
experiences.
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Timeline. A Gantt Chart timeline for implementation over quarters three and four of
2022 has been developed and is shown in Figure 3, although this projected timeline may be
somewhat fluid as the implementation process progresses. The Gantt Chart follows the four-step
action plan from Cullen & Adams (2012), which was previously evaluated. This timeline starts
the first week of July by creating awareness and interest which included a CVS quality meeting
presentation about the Posthoraxä phased approach on July 7th, as well as upcoming e-mail and
flyer information to staff; the flyer that is referenced in step 1.3 is included within the proposal as
Appendix I. After this step, building knowledge and commitment will start in August which
includes education for pertinent staff by the Posthoraxä representative, disseminating
educational PowerPoints and video to inpatient staff, and developing a quick reference guide
(QRG) on Posthoraxä. Promoting action and adoption then proceeds within step 3 with a current
projected start date of September 6th. Collection of real-time feedback and connecting with
change agents are also included within this step. The initial phase of 40 vests is projected to last
roughly a month's time, through the end of September. To pursue integration and sustained use,
step 4 concludes this process which involves sharing findings with stakeholders, collection of
feedback, and disseminating initial findings. Since six weeks must pass before patients should
complete the second Likert evaluation and 30 days pass before the STS criteria for DSWI is
fulfilled, the final statistical evaluations cannot be completed until about the end of November.
Summary Plan for Implementation
Effective implementation strategies are crucial for the success of an evidence-based
practice implementation. To create an action plan, which is step 14 in JHEBPM for nursing and
health professionals, a four-step approach from Cullen & Adams (2012) will be used to aid in
organizing the implementation. These four steps include creating awareness and interest,
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building knowledge and commitment, promoting action and adoption, and lastly pursing
integration and sustained use (Cullen & Adams, 2012). Since this is only a pilot intervention of a
small number of patients, the fourth step will be utilized more broadly if it is decided to
implement this intervention for all CVS patients.
For the first step of creating awareness and interest, there are several actions that will be
taken for use of the Posthoraxä sternal support vest. The DNP students will attend the unit
council meeting of the inpatient units and present information on the Posthoraxä sternal support
vest. This presentation will include evidence supporting implementation, anticipated impact, and
a timeline for when they can expect to see the vests on their units. Similarly, the DNP students
will attend staff meetings for the outpatient CVS clinic staff to create awareness in the outpatient
area as well. The DNP students will also connect with unit CNSs to ask that they include
Posthoraxä updates in their weekly e-mail to their respective units. Flyers with a brief amount of
information on the Posthoraxä sternal support vest will be posted in inpatient and outpatient
work areas; a developed staff informational flyer is included within Appendix I.
The second step is building knowledge and commitment. Education for correct sizing of
the vest will be given by the Posthoraxä rep to the small group of outpatient RNs who will be
responsible for screening and sizing patients; the two DNP students, DNP mentor, CVS CNSs
and NESs, and CVS dedicated physical and occupational therapists will also attend one of the
Posthoraxä representative lead educational sessions. To build knowledge across the inpatient
units, education will be disseminated to the different work areas in the form of a PowerPoint
with specific focus on what each work area will need to know about the product. This
PowerPoint will be created jointly by the DNP students and the CVS CNS utilizing resources
from the Posthoraxä representative. A roughly three-minute video provided by the company will
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also be included which shows how to measure for, don, and doff the vest. This education will be
given in person to the unit councils who will serve as change agents. Change agents as well as
unit staff will be given opportunities to share feedback and ideas on the project. When DNP
students round on the units they will informally assess the knowledge of the nurses and will
educate and connect them with resources as needed. Quick reference guides with basic
information on use will be distributed to the work areas to have on hand if questions arise. These
references guides will also be created jointly by the DNP students and CVS CNS with resources
from the Posthoraxä representative.
Promoting action and adoption comes next. Data collection will start in this step. The
ICU CNS will round on the work areas during normal business days to assess how
implementation is going and gather real-time feedback; the DNP students will also round the
areas when available during days off from work and school, but they will rely upon the CNS for
primary rounding. If issues or roadblocks arise, the multidisciplinary team will meet to discuss
potential solutions. The DNP students will touch base with change agents at this stage to troubleshoot and give them feedback on how implementation is going.
Once a change is made, pursuing integration and sustained use is the final step in
implementation. This is a pilot project, so parts of this step will be set aside until it is decided if
this pilot was successful enough to continue as a part of permanent practice. It is important to
share successes with both inpatient and outpatient staff. Along with successes, patient feedback
and adjustments to protocol based upon clinical or patient feedback should be shared as well.
Together, these four steps should ensure a successful implementation.
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Conclusion
Problem/Issue
As shown throughout this proposal, DSWIs are a grave issue within cardiac surgery.
They are associated with many negative consequences including high morbidity and mortality
rates as well as a significant impact on a hospital’s budget due to lack of reimbursement for
DSWI (Al-Ebrahim & Al-Ebrahim, 2020). The average hospital cost associated with a DSWI is
$62,000, and mortality rates from DSWI can be as high as 10% - 15% (Marzouk et al., 2019). A
2019 and 2020 chart abstraction of patients with DSWI at this project’s medical hospital
revealed, on average, 686% greater than for patients with a similar surgery and no DSWI, a
significantly greater cost per patient encounter. The patient, caregiver, and family also
experience negative consequences related to DSWI outside of obvious medical concerns, these
include increased expenses, time away from family, work implications, and prolonged stress,
among other negative experiences. Furthermore, the one-year mortality rate of patients with
DSWI in 2020 was found to be 33%, and 10% for 2021. The Quality Committee for the
department of Cardiac Surgery had identified an increase in DSWI to 0.5% in 2020 and 2021
from 0.3% in 2015 to 2019; the committee has tasked the two DNP students to investigate ways
to decrease this negative outcome trend for patients as well as the organization.
Evidence
A preliminary investigation into the literature surrounding DSWI prevention was
completed with the assistance of the medical center’s library resource. This initial review
identified numerous prevention measures concerning DSWI including HbA1C screening, post-op
sternal vest use, vancomycin paste applied to the sternum before closure, sternal plating, post-op
daily chlorhexidine/Hibiclensâ baths, post-op surgical bra use, and intra-operative sterile glove
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changes. All these prevention measures were viewed as possible interventions and were also
identified at various points within clinical time in the CVS department. After this preliminary
review of these preventative measures, the evidence supported the use of an HbA1C screening
protocol and post-op sternal vest utilization. A subsequent detailed review of articles related to
these two interventions was then completed for overall evidence and effectiveness. After
completing a synthesis and recommendation summary of articles related to these intervention
topics, it was determined that there was good evidence and consistent results which support their
implementation.
Theoretical Basis
The Johns Hopkins Nursing Evidence Based Model (JHNEBM) was chosen as the best
theoretical basis to guide this project proposal (Dang et al., 2022); it was also the EBP model that
was utilized for this project. The JHNEBM is an 18-step linear process which utilizes a
conceptual model and tools to help translate best evidence into practice; the unique aspect of the
JHNEMB is its interdisciplinary design, which includes nurses and their input (Dang et al., 2022;
Melnyk & Fineout-Overholt, 2019). The JHNEB model fits well with this proposal’s problem of
DSWI because it provides a clear three-part process of identifying a practice question, appraising
the evidence, and translation of the evidence. The model also provides resources that were
utilized for appraising evidence to ensure the appropriate level of implementation is done,
whether it supports intervention, piloting, or further study.
Plan for Application of the Evidence
The selected intervention for this project based on the evidence is use of a postoperative
sternal vest. Because the HbA1C screening protocol was already a part of the department’s
ERAS model, this intervention was not pursed further for the purposes of this DNP project.
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Thus, the postoperative sternal vest use is the primary focus of this project since the intervention
has yet to be readdressed after stalling in the first quarter of 2020. Given the evidentiary support,
the vest would be initiated once the patient is stabilized in the ICU, and it would be worn until
six weeks after surgery. The CVS department has been shown to be active in promoting change
to improve their practice and is a great environment to proceed with a process implementation
for a phased implementation of the Posthoraxä support vest.
The participants of this project are CVS patients at the medical center who meet specific
inclusion/exclusion criteria. A criterion scoring rubric would be done by the preoperative
outpatient clinic nurses, and the vest would be fitted for the patient at their preoperative nurse
visit. The initial phase of implementation of this intervention would involve 20 male and 20
female patients meeting criteria who also agree to wear the device postoperatively; this would be
paid for by the Posthoraxä company. Through the abstraction of 2019 and 2020 patients with
DSWI, the cost per patient encounter was found to be significantly more expensive when
compared to patients with similar surgeries who did not contract a DSWI. In comparison, a large
number of vests could be purchased with the savings from one prevented sternal wound
infection, assuming costs associated with 50% male patients and 50% female. Approval for
implied consent would be utilized in accordance with IRB requirements and reviewed through
the medical institution’s quality improvement guidelines.
To create an action plan, which is step 14 in the JHEBPM for nursing and health
professionals, a four-step approach from Cullen & Adams (2012) will be used to aid in
organizing the implementation. These steps include creating awareness and interest, building
knowledge and commitment, promoting action and adoption, and pursing integration and
sustained use (Cullen & Adams, 2012). Data preparation and analysis are two areas that can be
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assisted through the medical institution’s resources. The outcome of number of patients with
DSWI will be quantified as a percentage to easily compare to previous years rates of infections
and this year’s post-ERAS control group. The DNP students will collect data on process
outcomes in a shared spreadsheet within a CVS SharePoint database. There is also a systems
engineer who is working within the CVS department on process improvements who is available
to help with statistical calculations for the project and any other facilitating needs. Reporting and
discussions with the CVS quality committee will then be conducted to best address this issue
from a topic and data analysis standpoint for possible continuation of the intervention.
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Table 1
Database Search for Articles Pertaining to Possible Interventions for Post-Cardiac Surgery Sternal Wound Infection
Date of
Search

PICO Question

Keywords Used

Database/Source
Used (CINAHL,
OVID, Proquest,
PubMed, etc.)
CINAHL,
Embase, &
MEDLINE

Number of Hits
Listed

Reviewed

Used

491

80

10

02/01/22*

To explore sternal infections (after
sternal incision, infection,
cardiac surgery) and the best practice to sternal wound care,
prevent sternal infections.
prevention of sternal wound
infections, cardiac surgery,
sternotomy

04/05/22*

In adult cardiac surgery patients, how
does decreasing A1C prior to cardiac
surgery affect the rate of sternal wound
infections after cardiac surgery
compared to not decreasing A1C?

A1C or HbA1C or (glycated OVID MEDLINE
or glycosylated)
(hemoglobin or
haemoglobin), (sternal or
sternum) wound infection,
(heart or cardiac or
pericardial or coronary, or
myocardial or
cardiopulmonary) (bypass
or surgery or operation),
mediastinitis, diabetes

23

23

12

04/05/22*

In adult cardiac surgery patients, how
does wearing a sternal binder after
surgery affect deep sternal wound
infections compared to not wearing a
sternal binder?

sternal binder, sternal
support vest, deep sternal
wound infection, cardiac
surgery, mediastinitis

25

25

10

OVID MEDLINE

64

Date of
Search

PICO Question

Keywords Used

Database/Source
Used (CINAHL,
OVID, Proquest,
PubMed, etc.)
OVID MEDLINE

Number of Hits
Listed

Reviewed

Used

21

21

4

04/06/22*

In cardiac surgery patients, how does
sternal vancomycin paste applied to the
sternum before closure affect sternal
wound infection rates compared to
patients who did not have vancomycin
paste on their sternum?

vancomycin (paste or
topical or cutaneous),
sternal wound infections,
mediastinitis, (heart or
cardiac or pericardial or
coronary, or myocardial or
cardiopulmonary) (bypass
or surgery or operation)

04/06/22*

In adult cardiac surgery patients, how
does sternal plating at closure affect
sternal wound infections compared to
no sternal plating?

cardiac surgery, sternal
plates, sternal plating,
sternal wound infections,
mediastinitis, internal
fixators, bone plates

OVID MEDLINE

53

53

9

04/06/22*

In adult cardiac surgical patients, how
do daily Hibiclensâ baths compared to
no Hibiclensâ baths affect sternal
wound infection rates?

Hibiclens baths, cardiac
surgery, sternal wound
infections, mediastinitis,
chlorhexidine

OVID MEDLINE

17

17

8

04/08/22*

In adult cardiac surgery patients, how
does wearing a surgical bra after
surgery affect deep sternal wound
infections compared to not wearing a
surgical bra?

surgical bras; post-surgical
bras; cardiac surgery;
sternal wound infections

CINAHL,
Embase, &
MEDLINE

3

3

2

65

Date of
Search

PICO Question

04/08/22*

In cardiac surgery, how does the use of
replacing sterile gloves while operating
affect surgical related infections
compared to using the same sterile
gloves throughout the surgical case?
(Depending on the number of articles,
the search could be broadened to all
types of surgeries)

04/20/22

Not Applicable (NA)

Keywords Used
cardiac surgery, changing
sterile gloves, operating
room, operation, sternal
wound infections,
mediastinitis

Database/Source
Used (CINAHL,
OVID, Proquest,
PubMed, etc.)
Scopus (includes
MEDLINE) &
Google Scholar

Number of Hits
Listed

Reviewed

Used

18

13

13

((deep sternal wound
PubMed
4
3
1
infection OR mediastinitis)
AND (prevention)) AND
(cardiac surgery OR
cardiovascular surgery OR
CABG OR coronary artery
bypass graft)) AND (sternal
support vest OR sternal
binder OR Posthorax OR
stern-e-fix corset OR
sternum brace OR sternum
support)
*Note: All initial searches were completed by the medical center’s library staff and required a PICO question on each specific
intervention and keywords; a follow-up search in other search engines was then conducted (PubMed, CINAHL) using the same search
parameters and keywords, but yielded only the study associated with the 04/20/22 search
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Table 2
Summary of Evidence for DSWI Prevention Measures and Decision to Implement or Discard the
Measure Based Upon the Evidence
Implement

Discard

HbA1C Screening: Articles used a variety of
HbA1C cutoff points for their studies. All
studies involved cardiac surgical patients,
though some were specific subsets. Most
studies showed a significantly greater number
of patients with an elevated HbA1C having
sternal wound infections, or even an increase
in risk for DSWI per unit HbA1C increase.
Post-op Sternal Vest Use: All the studies &
articles of varying levels of evidence and rigor
supported the use of a sternal vest to reduce
DSWI; included are two large multi-center
Level 1 studies. Posthoraxä was specifically
studied in multiple of these studies. There is
strong evidence to support the use of a sternal
vest such as Posthoraxä.

Sternal Plating Closure Technique: Most of the literature
demonstrates there is little to no benefit to sternal plating in
regard to preventing sternal wound infections, notably it doesn’t
show any negative outcomes either. Many articles looked at
how sternal plating affected sternal stability and patient’s pain,
but not sternal wound infections. Many articles investigated the
effect of sternal plating after a patient had a DSWI, or compared
closure techniques, but didn’t include sternal plating.
*Post-op Daily Chlorhexidine Baths: No studies were found
regarding chlorhexidine showering post-operatively, so there is
no evidence available that could support the use of
chlorhexidine showering post-operatively. Current research only
studied the effects of chlorhexidine showering pre-operatively.
Most of the studies utilized this intervention as a part of an
infection reduction bundle/protocol. All studies did show
benefits pre-operatively regarding chlorhexidine use.

Vancomycin Paste to the Sternum Before Closure: After
reviewing the literature, there is controversy surrounding this
intervention. There were no negative outcomes reported, but the
initial study that many later studies reference has noted
flaws/limitations in the study design comparison of its control
and intervention groups. The one definitively supportive study
uses a vancomycin sponge, not a paste.
Post-op Surgical Bra Use: There were few articles/studies
found regarding surgical bras and cardiac surgery, creating a
limitation of evidentiary support. The two articles found, which
are lower-level evidence, both did not directly study DSWI.
However, if Posthoraxä is implemented, there would be no
need for greater use of the surgical bra.
Intra-Op Sterile Glove Changes: There were no studies found
which specifically investigated sterile glove changes in open CV
surgery. However, in broadening the search parameters of any
surgical type, there was no consensus that glove changes had an
impact on SSI. Double gloving is a standard practice. The
studies which found significance in glove changes, all had
varying parameters or findings of when to conduct the change.
Though the evidence was inconclusive, changing the outer pair
of gloves is a simple intervention that does not carry any
additional risks, except for the time needed to switch gloves.
*Note: the terms “Hibiclensâ” and “chlorhexidine” are used interchangeably
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Table 3
HbA1C Screening Intervention Synthesis and Recommendation
Strength
Level

Overall Quality
Rating

Number of
Sources
(Quantity)

(strong, good, low)

Level I
Experimental studies
Level II
Quasi-experimental
studies
Level III
Nonexperimental,
including qualitative
studies

Level IV
Clinical practice
guidelines or consensus
panels
Level V
Literature reviews,
QI, case reports, expert
opinion

NA

0

NA

0

Good

12

NA

0

NA

0

Synthesized Findings with Article
Number(s)
(This is not a simple restating of information
from each individual evidence summary—
see directions)

Samples consisted of adult cardiac
surgical patients; the type of cardiac
surgery performed did vary by article
which could influence the outcome.
Overall, the evidence showed a strong
relationship between elevated HbA1C
and DSWI.

Where does the evidence show consistency?
The evidence shows consistency in the relationship between increased HbA1C and deep sternal wound
infection.

Where does the evidence show inconsistency?
The evidence used a variety of A1C levels as cutoff points to make comparisons, so it would be
difficult to say at what HbA1C a patient should require an intervention. Not all studies focused on
DSWI, some looked at superficial wound infections, and some did not complete calculations for the
different types of infections.

Best evidence recommendations (taking into consideration quantity, consistency, and
strength of the evidence):
In cardiac surgical patients, the evidence demonstrates a consistent relationship between elevated
HgA1C and deep sternal wound infections.
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Table 3 Continued
Based on your synthesis, select the statement that best describes the overall
characteristics of the body of evidence?
☐ Strong & compelling evidence, consistent results → Recommendations are reliable; evaluate for
organizational translation.
X Good evidence & consistent results → Recommendations may be reliable; evaluate for risk and
organizational translation.
☐ Good evidence but conflicting results → Unable to establish best practice based on current evidence;
evaluate risk, consider further investigation for new evidence, develop a research study, or discontinue
the project.
☐ Little or no evidence → Unable to establish best practice based on current evidence; consider further
investigation for new evidence, develop a research study, or discontinue the project.
Note: Level of Evidence is based on the Johns Hopkins rating scale (Dang et al., 2022). From “Johns Hopkins
evidence-based practice model for nursing and healthcare professionals: Synthesis and recommendations tool
(Appendix H),” by Johns Hopkins Health System/Johns Hopkins School of Nursing, 2022. Copyright 2022 by
Johns Hopkins Health System/Johns Hopkins School of Nursing.
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Table 4
Post-op Sternal Vest Use Intervention Synthesis and Recommendation
Strength
Level

Overall Quality
Rating

Number of
Sources
(Quantity)

(strong, good, low)

Level I
Experimental studies

Good

7

Level II
Quasi-experimental
studies
Level III
Nonexperimental,
including qualitative
studies

NA

0

Good

1

NA

0

Low

4

Level IV
Clinical practice
guidelines or consensus
panels
Level V
Literature reviews,
QI, case reports, expert
opinion

Synthesized Findings with Article
Number(s)
(This is not a simple restating of information
from each individual evidence summary—
see directions)

Samples consisted of adult cardiac
surgical patients; the type of cardiac
surgery performed did vary by article
which could influence the outcome. Only
three of the studies had a sample size
larger than 750 patients, with the least
having only 15 patients. The two
strongest studies are multicenter with
over 1500 patients included. Overall, the
evidence showed a strong relationship
between sternal vest use and decreased
DSWI rates.

A large sample size of over 3,000
patients was utilized, but they only
studied one type of surgical approach.
Overall, the evidence showed a
significant relationship which decreased
DSWI, but limitations existed which
impacts the overall quality.

Three literature reviews and one case
study. Limitations that decrease the
quality were present such as compliance
and the need for expert opinions based
on results, but all four support the use of
a sternal vest device.

Where does the evidence show consistency?
The evidence shows consistency in the relationship between postoperative sternal vest use and a
decrease of deep sternal wound infection.
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Table 4 Continued
Where does the evidence show inconsistency?
The evidence did not all implement the same sternal vest, nor not all defined which definition of DSWI
they utilized. Five studies used the Posthoraxä and one used the Stern-E-Fix, with the others not
disclosing this information. The sample sizes and levels of evidence greatly varied as well. Not all
studies focused specifically on DSWI; some studies looked at other measures such as sternal nonunion, which then an inference was made that DSWI risk would be reduced with better sternal union.

Best evidence recommendations (taking into consideration quantity, consistency, and
strength of the evidence):
In cardiac surgical patients, the evidence demonstrates a consistent relationship between use of a
postoperative sternal vest and a decrease in deep sternal wound infections.

Based on your synthesis, select the statement that best describes the overall
characteristics of the body of evidence?
☐ Strong & compelling evidence, consistent results → Recommendations are reliable; evaluate for
organizational translation.
X Good evidence & consistent results → Recommendations may be reliable; evaluate for risk and
organizational translation.
☐ Good evidence but conflicting results → Unable to establish best practice based on current evidence;
evaluate risk, consider further investigation for new evidence, develop a research study, or discontinue
the project.
☐ Little or no evidence → Unable to establish best practice based on current evidence; consider further
investigation for new evidence, develop a research study, or discontinue the project.
Note: Level of Evidence is based on the Johns Hopkins rating scale (Dang et al., 2022). From “Johns Hopkins
evidence-based practice model for nursing and healthcare professionals: Synthesis and recommendations tool
(Appendix H),” by Johns Hopkins Health System/Johns Hopkins School of Nursing, 2022. Copyright 2022 by
Johns Hopkins Health System/Johns Hopkins School of Nursing.
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Table 5
Johns Hopkins Nursing Process for Evidence-based Practice – DSWI Paired Intervention
Step: Process

Topic/Recommendation Application
PRACTICE QUESTION

Step 1: Recruit
interprofessional team

-Creation of a two-person Winona State University DNP student team who also works
within the project’s medical facility
-Conversations and emails with hospital interdisciplinary teams to develop project
ideas and possible pertinent stakeholders
-Attending pertinent unit council meetings to develop awareness of the team and new
project development
-Attending practice sub-committee and quality meetings to build awareness and new
project development

Step 2: Develop and refine -Identify problem areas in clinical practice
the EBP question
-Form preliminary question in PICO format
-Conduct preliminary literature review
-Utilize interdisciplinary team and quality committee input
-Apply DNP and faculty mentor input
Step 3: Define the scope of -Scope: Post-surgical cardiac patients with a sternal incision approach
the EBP question and
identify stakeholders
-Stakeholders: Unit RNs, CNS, NES, nurse manager, inpatient and outpatient
providers (consultants/surgeons, residents, APRNs, PAs), CVS quality committee, data
abstractors, quality engineer, and patients/families
Step 4: Determine
responsibility for project
leadership

-The DNP students will be the primary leaders who guide the project throughout the
process
-DNP and faculty mentors will help to guide the DNP students
-Other pertinent stakeholder leaders will be identified for each portion of the project
-Leaders will be responsible for organizing meetings, keeping within the timeline,
developing the readiness for change and project proposal, final edits to any paperwork,
and promoting general communication

Step 5: Schedule team
meetings

-Utilize zoom for face-to-face meetings and email chains to keep up to date on project
developments/updates
-To ensure maximum staff availability with meetings, they will be pre-scheduled
around normal work times
-Provide options for meetings to be within or above FTE for paid staff members
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Step: Process

Topic/Recommendation Application
EVIDENCE

Step 6: Conduct internal
and external search for
evidence

-Preliminary external evidence analysis of possible interventions collected through
literature search of databases including CINAHL, OVID, Embase, Medline, PubMed,
& Google Scholar with the assistance of the medical institution’s librarians. Boolean
phrasing and inclusion criteria will be set appropriately.
-Detailed external evidence analysis of select interventions is then conducted by the
DNP students after completing and passing the preliminary external evidence analysis
-Internal evidence collected through collaboration cardiac post-surgical units and the
outpatient clinic including their current sternal infection incidence, prevalence, and
prevention practices

Step 7: Appraise the level -Utilize the Johns Hopkins Levels and Quality of Evidence Guide
and quality of each piece of
evidence
-Utilize the Johns Hopkins Research Appraisal Appendices
Step 8: Summarize the
individual evidence

-The two DNP students appraise and summarize the preliminary evidence articles,
including an overall preliminary summary table
-Create a “Keep or Discard” table for articles related to the selected preliminary
analysis. This includes the rationale for the decision to include or exclude literature for
these selected interventions which passed preliminary analysis
-Complete a detailed evidence analysis for the selected interventions in accordance
with Johns Hopkins Research Appraisal, Appendix G

Step 9: Synthesize overall
strength and quality of
evidence

-Complete an overall evidence synthesis for the selected interventions in accordance
with Johns Hopkins Research Appraisal, Appendix H

Step 10: Develop
recommendations for
change based on evidence
synthesis
• Strong, compelling
evidence, consistent
results
• Good evidence,
consistent results
• Good evidence,
conflicting results
• Insufficient or absent
evidence

-Utilize the overall evidence synthesis to recommend the intervention’s use based upon
the literature
-Present these literature findings to the DNP and faculty mentors as well as pertinent
stakeholders, including CVS surgeons and CVS quality committee members
-Create a cost-benefit analysis, as applicable, for each selected intervention
-Develop final recommendations based on the evidence, clinical expertise, and patient
preferences and values
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Step: Process

Topic/Recommendation Application
TRANSLATION

Step 11: Determine fit,
feasibility, and
appropriateness of
recommendation(s) for
translation path

-Ensure recommendations are supported by evidence, clinical expertise, and patient
preferences and values
-Ensure recommendations coincide with the mission, vision, and goals of the
organization in question
-Ensure the assessments and interventions are within the scope and standards of
practice for each member of the interdisciplinary team and proper training is available

-Ensure the organization has the necessary support and resources required to
implement the action plan for delirium assessments and prevention interventions
Step 12: Create action plan -Utilize an action planning tool to aid in creating proper steps (Cullen & Adams,
2012)
1.
2.
3.
4.

Create Awareness & Interest
Build Knowledge & Commitment
Promote Action & Adoption
Pursue Integration & Sustained Use

-Set SMART goals for implementation
1.
2.
3.
4.
5.

Specific
Measurable
Actionable/attainable
Realistic
Timely

-Identify the education, support, and resources needed to implement the selected
interventions
Step 13: Secure support and -Resources needed to implement the action plan include:
resources to implement
action plan
1. A Posthoraxä representative to educate select staff
2. CNS & NES involvement in educating all other staff
Step 14: Implement action -Provide staff targeted required education sessions for CVS RN and provider staff in
plan
the outpatient and inpatient setting
1.
2.
3.

Educational PowerPoint developed by DNP students and CNS
Posthoraxä company-created video
Posthoraxä company representative education to identified staff

-Set a start date for rolling out the evidence-based practice project parameters and
communicate with the interdisciplinary team via several modes, including:
1.
2.
3.

Emails
Flyers on CVS bulletin boards and nursing stations (See Appendix I)
Daily staff briefings

-Be present on-site during implementation
1.
2.
3.

Answer questions and provide support to staff in real time
Aid in device use and documentation
Monitor assessment and intervention compliance
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Step: Process

Topic/Recommendation Application
TRANSLATION Cont.

Step 15: Evaluate outcomes -Utilize real-time feedback and chart audits to ensure assessments are being completed
per action plan
-The to ensure all aspects are being appropriately incorporated into practice when
clinically appropriate
-Gather data on:
1.
2.
3.
4.

Staff compliance with vest utilization
Patient compliance with use
DSWI rate comparisons
Patient and staff Likert surveys (See Appendices E, F, and G)

Step 16: Report outcomes to When able, contact the following individuals/groups/organizations regarding the
stakeholders
outcomes of the evidence-based practice project:
• Patients/families, interdisciplinary healthcare team, hospital
administration, insurance providers, licensing bodies (Joint Commission,
Magnet designation/ANCC), AACN
Step 17: Identify next steps -Meet with the practice quality committee to discuss the implementation, evaluation,
and options for dissemination of findings
-Meet with the DNP and faculty mentors for further needs
Step 18: Disseminate
findings

-Create a presentation of the evidence-based practice project. Options include:
1.
2.
3.

PowerPoint presentation
Informational poster
Informational flyers

-May submit abstract to present at a local, regional, or national critical care conference
-Publish findings in a journal of nursing science

Note: Level of Evidence is based on the Johns Hopkins rating scale (Dang et al., 2022). Table is adapted from
Figure 14.10 (page 415) in “Evidence-based practice: In nursing and healthcare,” by Melnyk & FineoutOverholt 2019. Original Copyright 2012 by John Hopkins Hospital/The John Hopkins University.
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Table 6
Patient Eligibility Criteria for Posthoraxä Intervention Use Checklist
Patient Eligibility Criteria for Posthoraxä Intervention Use
Outpatient Scoring Rubric
Criteria
Present (mark X if present)
Diabetes diagnosis
Bilateral Internal Mammary Artery takedown (surgery type)
Obesity (BMI 35 or greater)
Large Breasts (subjective OR cup size D or greater)
Osteoporosis diagnosis OR female 65+ years old
Active smoker
COPD diagnosis
Repeat sternotomy
Total Xs
If a total Xs score of 2 or greater is present, then the patient would qualify for a Posthoraxä
device postoperatively. Fitting will be completed during the outpatient preoperative visit.
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Table 7
Cost-Benefit Analysis for Posthoraxä Intervention
Item

Cost

Notes

Spending Costs
Posthorax TM support vest for men

$182

Posthorax TM support vest for women

$268

Additional insert for women with breasts Bcup or larger

DNP Students

$0

Development, education, and analysis of the
project through a doctoral university
curriculum; considered gifs in kind via time.
If experienced employed staff were paid for
the approximately 360 combined hours, it
would cost roughly $20,000.

Cardiovascular Department CNS & NES

$0

Educating and implementing EBP is
considered part of their already assigned
roles. Dedicated time for this project for
approximately 40 hours of work costs about
$2,200.

$XXXX

This is the cost charged to patient/insurance,
not what the hospital receives or loses

Benefiting Costs
Average additional cost of encounter
with a sternal wound infection compared
to an encounter with the same surgery
and no sternal wound infection for 2020
and 2021

Net Cost Differential
§ A very large number of vests could be purchased with the savings from one prevented sternal wound
infection (assuming 50% male patients and 50% female)

§ At full price, a trial of 20 male and 20 female vests would cost the department $9,000 total
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Figure 1
PRISMA Diagram Reflecting Study Criteria for Inclusion or Exclusion

Note: Adapted from “The PRISMA 202 Statement: An Updated Guideline for Reporting Systematic Reviews”,
by M. J. Page et al., 2021, British Medical Journal 372(71), https://doi.org/10.1136/bmj.n71

‘
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Figure 2
Johns Hopkins Nursing Evidence-based Practice Model Flowchart

Note: From “Johns Hopkins evidence-based practice for nurses and healthcare professionals: Model and
guidelines (4th ed.),” by Dang, D., Dearholt, S., Bissett, K., Ascenzi, J., & Whalen, M., 2022, Indianapolis, IN:
Sigma Theta Tau International (https://www.hopkinsmedicine.org/evidence-basedpractice/ijhn_2017_ebp.html). Copyright 2022 by Johns Hopkins Center for Evidence-Based Practice.
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Figure 3
Implementation Timeline of Posthoraxä Intervention within the CVS Department: 2022 Third & Fourth Quarters
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Appendix A
Inclusion/Exclusion Table of Intervention Related Articles
Table A1
Rationale for Literature Included and Excluded Concerning HbA1C Relation to DSWI
Author &
Date
Included Articles/Studies

Title

Included for Further Analysis or
Excluded

The Association Between Preoperative Hemoglobin A1C
Included: Measured patient’s HbA1C and
Bardia et al. and Postoperative Glycemic Variability on 30-Day Major
major adverse outcomes after surgery
(2017)
Adverse Outcomes Following Isolated Cardiac Valvular
including sternal infection
Surgery
Impact of Preoperative Glycometabolic Status on
Corazzari et
Outcomes in Cardiac Surgery: Systematic Review and
al. (2021)
Meta-Analysis

Included: Measured HbA1C and sternal
wound infection rates

Gatti et al.
(2017)

Included: Measured HbA1C and sternal
wound infection rates

Glycated Hemoglobin and Risk of Sternal Wound
Infection After Isolated Coronary Surgery

Preoperative Hemoglobin A1c Predicts Sternal Wound
Halkos et al.
Infection After Coronary Artery Bypass Surgery with
(2008a)
Bilateral Versus Single Internal Thoracic Artery Grafts

Included: Measured HbA1C and deep
sternal wound infection rates

Elevated Preoperative Hemoglobin A1c Level Is
Halkos et al.
Predictive of Adverse Events After Coronary Artery
(2008b)
Bypass Surgery

Included: Measured HbA1C and deep
sternal wound infection rates

Khan et al.
(2019)

Effect of Glycemic Control on Mortality and Infections in
Included: Measured HbA1C and sternal
Patients Undergoing Coronary Artery Bypass Grafting: A
wound infection rates
Genesee County Experience

Kim et al.
(2020)

Influence of Preoperative Hemoglobin A1c on Early
Included: Measured HbA1C and deep
Outcomes in Patients with Diabetes Mellitus Undergoing
sternal wound infection rates
Off-Pump Coronary Artery Bypass Surgery

Narayan et al. Preoperative Glycosylated Hemoglobin: A Risk Factor for Included: Measured HbA1C and deep
(2017)
Patients Undergoing Coronary Artery Bypass
sternal wound infection rates
Utility of Glycated Hemoglobin Screening in Patients
Nicolini et al.
Undergoing Elective Coronary Artery Surgery:
(2018)
Prospective, Cohort Study from the E-CABG Registry

Included: Measured HbA1C and deep
sternal wound infection rates

Impact of Elevated Glycosylated Hemoglobin on Hospital
Ramadan et
Included: Measured HbA1C and sternal
Outcome and 1 Year Survival of Primary Isolated
al. (2017)
wound infection rates
Coronary Artery Bypass Grafting Patients
Van de
Hemoglobin A1c and Preoperative Glycemia as a Decision
Included: Measured HbA1C and sternal
Eynde
Tool to Help Minimize Sternal Wound Complications: A
wound complication rates
et al. (2021) Retrospective Study in OPCAB Patients
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Author &
Date
Excluded Articles/Studies

Title

Included for Further Analysis or
Excluded

Alserius et al. Elevated Glycosylated Haemoglobin (HbA1c) Is a Risk
(2008)
Marker in Coronary Artery Bypass Surgery

Excluded: Not conducted within the last
10 years and enough studies exist within
that timeframe to rely upon

Biancari &
Giordano
(2019)

Excluded: Too many limitations and
questions about legitimacy. Though it
states that 14 studies and over 17,000
patients were included, little to no further
information is provided within the only 3
total pages. The article also only gives one
odds ratio for DSWI, with no p-value or
detailed statistics.

Glycated Hemoglobin and the Risk of Sternal Wound
Infection After Adult Cardiac Surgery: A Systematic
Review and Meta-Analysis

Stapler Versus Polyamide Sutures for Skin Closure for
Excluded: Focus is relationship between
Jadhao et al.
Sternal Wounds in Coronary Artery Bypass Graft Surgery material used to close patient and surgical
(2020)
– Our Experience
site infection
Excluded: Focused on difference in
outcomes between bilateral internal
mammary artery grafts and single internal
mammary artery grafts
Excluded: Correlated intraoperative
Lessen et al. Our Experience with Two Cardioplegic Solutions:
hyperglycemia with DSWI, not
(2012)
Dextrose Versus Non-Dextrose in Adult Cardiac Surgery
preoperative A1C level
Excluded: Compared graft types to sternal
Lev-Ran et Bilateral Internal Thoracic Artery Grafting in Insulinwound infection rates in diabetics, did not
al. (2013)
Treated Diabetes
look specifically at A1C levels
Kazui et al.
(2021)

Short-Term Risk of Bilateral Internal Mammary Artery
Grafting in Diabetic Patients

Paone (2019)

Hemoglobin A1c and Deep Sternal Wound Infection: It's Excluded: Editorial commentary on an
Not Just About the Number
article

Okonta &
Anbarasu
(2012)

Omentoplasty as an Effective Surgical Modality for
Excluded: Studied effectiveness of
Managing a High-Risk Patient with Deep Sternal Wound
omental flaps to treat DSWI
Infection

Sato et al.
(2010)

The Association of Preoperative Glycemic Control,
Intraoperative Insulin Sensitivity, and Outcomes After
Cardiac Surgery

Increased Glycemic Variability in Patients with Elevated
Subramaniam
Preoperative HbA1C Predicts Adverse Outcomes
et al. (2014)
Following Coronary Artery Bypass Grafting Surgery

Excluded: Not within the last 10 years and
enough studies exist within that timeframe
to rely upon
Excluded: Focus was on the effect of
postoperative glycemic variability on
major adverse events, not A1C on DSWI

Excluded: All articles in this best evidence
Is There a Role for HbA1c in Predicting Mortality and
Tennyson et
topic are greater than 10 years old (2008Morbidity Outcomes After Coronary Artery Bypass Graft
al. (2013)
2012) and enough studies exist that are
Surgery?
within 10 years of age
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Table A2
Rationale for Literature Included and Excluded Concerning Sternal Vest Use Postoperatively
Relation to DSWI
Title

Included for Further Analysis or
Excluded

Albert et al.
(2019)

Total Arterial Myocardial Revascularization Using
Bilateral Internal Mammary Arteries and The Role of
Postoperative Sternal Stabilization to Reduce Wound
Infections in a Large Cohort Study

Included: Posthraxä vest implemented to
assess for impact on sternal wound
complications

Brocki et al.
(2010)

Precautions Related to Midline Sternotomy in Cardiac
Included: Literature review on stress
Surgery: A Review of Mechanical Stress Factors Leading
factors associated with sternal infection
to Sternal Complications

Author &
Date
Included Articles/Studies

A Randomized Trial to Assess the Contribution of a
Included: Posthraxä vest implemented to
Caimmi et al.,
Novel Thorax Support Vest (Corset) in Preventing
assess for impact on sternal
(2017)
Mechanical Complications of Median Sternotomy
healing/separation
Sternal Dehiscence in Patients with Moderate and Severe Included: COPD patients studied to assess
Celik et al.
Chronic Obstructive Pulmonary Disease Undergoing
for impact on sternal dehiscence difference
(2011)
Cardiac Surgery: The Value of Supportive Thorax Vests with a sternal support vest intervention
El-Ansary et Control of Separation in Sternal Instability by Supportive Included: Three sternal supportive devices
al. (2008)
Devices: A Comparison of an Adjustable Fastening
were compared for impact on sternal
Brace, Compression Garment, and Sports Tape
separation
Included: Posthraxä vest implemented to
Gorlitzer et al. A Newly Designed Thorax Support Vest Prevents
assess for impact on sternal
(2009)
Sternum Instability After Median Sternotomy
healing/separation/DSWI
A Prospective Randomized Multicenter Trial Shows
Included: Multicenter Posthraxä vest
Gorlitzer et al.
Improvement of Sternum Related Complications in
study to assess for impact on sternum
(2010)
Cardiac Surgery with The Posthorax Support Vest
related complications, including DSWI
Prevention of Sternal Wound Complications After
Gorlitzer et al.
Included: Larger multicenter Posthraxä
Sternotomy: Results of a Large Prospective Randomized
(2013)
vest study to assess for impact on DSWI
Multicentre Trial
Klement &
Supportive Treatment Using a Compression Garment
Included: Case Study on the impact a
Herrmann
Vest of Painful Sternal Instability Following Deep
sternal compression vest my provide for a
(2010)
Surgical Wound Infection: A Case Report
patient with complicated sternal healing
Prevention of Sternal Dehiscence with The Sternum
Included: Stern-E-Fix corset implemented
Tewarie et al.
External Fixation (Stern-E-Fix) Corset – Randomized
to assess for impact on sternal wound
(2012)
Trial in 750 Patients
infections
Included: Literature review regarding the
Tsang et al. Do External Support Devices Reduce Sternal Wound
impact of external support devices on
(2016)
Complications After Cardiac Surgery?
sternal wound complications
Included: Literature review regarding the
Vos et al.
Prevention of Deep Sternal Wound Infection in Cardiac
prevention measures to DSWI, including
(2018)
Surgery: A Literature Review
the use of a sternal vest
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Author &
Date
Excluded Articles/Studies

Title

Included for Further Analysis or
Excluded

Aykut et al.
(2011)

Figure-of-Eight Versus Prophylactic Sternal Weave
Closure of Median Sternotomy in Diabetic Obese
Patients Undergoing Coronary Artery Bypass Grafting

Excluded: Sternal closure techniques are
compared, not a sternal vest intervention

Barile et al.
(2018)

Cardioprotection by Cardiac Progenitor Cell-Secreted
Exosomes: Role of Pregnancy-Associated Plasma
Protein-A

Excluded: A sternal vest intervention is not
used

Blake et al.
(2003)

Alfentanil Infusion as a Component of Intravenous
Anaesthesia for Coronary Artery Bypass Surgery with
"Fast-Track" Recovery

Excluded: A sternal vest intervention is not
used

Dogan et al.
(2005)

Minimally Invasive Port Access Versus Conventional
Mitral Valve Surgery: Prospective Randomized Study

Excluded: A sternal vest intervention is not
used

Fain et al.
(2010)

Human Epicardial Adipokine Messenger RNAs:
Comparisons of Their Expression in Substernal,
Subcutaneous, and Omental Fat

Excluded: mRNAs are analyzed, not
sternal vest use

Fuchigami et Staged Delayed Sternal Closure Using a Binder Clip
al. (2016)
After Pediatric Cardiac Surgery

Excluded: A binder clip intervention
analyzed, not a sternal vest

Rationale and Options for Choosing an Optimal Closure
Excluded: Sternal closure techniques are
Gandhi (2019) Technique for Primary Midsagittal Osteochondrotomy of
compared, not a sternal vest intervention
the Sternum
Kok et al.
(2017)

Neuronal Damage Biomarkers in the Identification of
Patients at Risk of Long-Term Postoperative Cognitive
Dysfunction After Cardiac Surgery

Kovacikova et Thyroid Hormone Metabolism in Pediatric Cardiac
al. (2002)
Patients Treated by Continuous Povidone-Iodine
Irrigation for Deep Sternal Wound Infection

Excluded: Biomarkers are analyzed, not
sternal vest use
Excluded: Thyroid hormone metabolism is
analyzed in connection to DSWI, not
sternal vest use; also only studied pediatric
patients, not adults

Kovacikova et Thyroid Hormone Status After Cardiac Surgery in
Excluded: Thyroid hormone metabolism is
al. (2003)
Infants with Delayed Sternal Closure and Continued Use analyzed, not sternal vest use; also only
of Cutaneous Povidone-Iodine
studied pediatric patients, not adults
Kovacikova et Thyroid Function and Ioduria in Infants After Cardiac
al. (2005)
Surgery: Comparison of Patients with Primary and
Delayed Sternal Closure

Excluded: Thyroid function is analyzed,
not sternal vest use; also studied the infant
population, not adults
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Author &
Title
Date
Excluded Articles/Studies Continued

Included for Further Analysis or
Excluded

Effects of A Novel Pneumatic Vest on Postoperative
Laurikka et al.
Pain and Lung Function After Coronary Artery Bypass
(1998)
Grafting

Excluded: A vest intervention is studied,
but in relation to pain and lung function,
not DSWI; older article as well

O'Rullian et
al. (1998)

Excluded: A sternal vest intervention is not
used; older article as well

The Effects of Haemofiltration on Cefazolin Levels
During Cardiopulmonary Bypass

Santarpino et Sternal Wound Dehiscence from Intense Coughing in a
al. (2013)
Cardiac Surgery Patient: Could It Be Prevented?

Excluded: A case study that proposes
sternal dehiscence interventions, but does
not discuss DSWI impact

Cerebral Oxygenation Impairment and S-100beta Protein
Tsaousi et al.
Excluded: A sternal vest intervention is not
Release During Off-Pump Coronary Artery
(2013)
used
Revascularization
Ulicny et al.
(1990)

Sternotomy Infection: Poor Prediction by Acute Phase
Response and Delayed Hypersensitivity

Excluded: A sternal vest intervention is not
used; older article as well
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Appendix B
Preliminary Analysis of Included Articles Related to All Possible Interventions
Table B1
Summary of Evidence for HbA1C Relationship to DSWI in Cardiac Surgery Patients
Author &
Date

Bardia et al.
(2017)

Corazzari et
al. (2021)

Gatti et al.
(2017)

Halkos et al.
(2008a)

Halkos et al.
(2008b)

Khan et al.
(2019)

Level of
Intervention/solution
Evidence

Level III

Level III

Level III

Level III

Level III

Level III

HbA1C <6.5% compared
to greater than or equal to
6.5%

HbA1C with a cutoff point
of either 7% or 7.5%

HbA1C <8.6% compared
to greater than or equal to
8.6% (8.6 found to be best
cutoff as a predictor for
risk)

Measured HbA1C preop
and measured DSWI
occurrence.

HbA1C < 7% compared to
greater than or equal to
7%

HbA1C <7% compared to
greater than or equal to
7%

Study Outcomes

Supports
Use as a
Prevention
Measure

Increased HbA1c did not show a
statistically significant difference
in MAEs (major adverse events)
in the study. Only studied valve
patients

No

Preoperative glycosylated
hemoglobin was associated with
the lowest risk of sternal wound
infections, p = 0.003 (7.5%), p <
0.0001 (7%)

Yes

Baseline HbA1C was
significantly higher in patient
with SWI (sternal wound
infection) (p < 0.0001) (looked at
all sternal wound infections, not
deep one specifically)

*Yes

For each unit increase in HbA1C,
there was a 31% increased risk of
DSWI (AOR 1.31, 95% CI 1.16 –
1.49, P = 0.001). Patients with
HbA1c 7% had 2.88-fold increase
in DSWI compared with patients
with HbA1c < 7%.

*Yes

For each unit increase in HbA1C,
there was a significantly
increased risk of myocardial
infarction and deep sternal wound
infection. (p = 0.029)

*Yes

There was not a statistically
significant difference in the
occurrence of sternal wound
infections between patients with
an HbA1C < 7% or greater than
or equal to 7%. (p > 0.999)

*No
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Author &
Date
Kim et al.
(2020)

Lev-Ran et
al. (2012)

Narayan et
al. (2017)
Nicolini et
al. (2018)

Ramadan et
al. (2017)

Van de
Eynde et al.
(2021)

Level of
Intervention/solution
Evidence

Study Outcomes

Supports
Use as a
Prevention
Measure

Level III

HbA1C <7% compared to
greater than or equal to
7%

DSWI was significantly more
frequent in the Hgb HbA1C >7%
group (p = 0.19)

Yes

Level III

Assessed risks and
outcomes related to BITA
(bilateral internal thoracic
artery) CABG (coronary
artery bypass grafting)
patients with insulin
dependent diabetes.

Recommends postponing
operation when HbA1C is 8.7%
or greater

NA

HbA1C <6.5% compared
to greater than or equal to
6.5%

DSWI occurred significantly
more often in patients with a
HbA1C greater than or equal to
6.5% (p = 0.004)

Yes

HbA1C <7% compared to
greater than or equal to
7%

HbA1C > 7% is a significant
predictor of deep sternal wound
infection (p = 0.001, 3.8% v
1.3%)

Yes

Level III

HbA1C greater than, or
less than or equal to 7%
(no interventions just
observation of HbA1C)

No statistically significance
difference in deep sternal wound
infection rates between the two
groups (p = 0.152) A1C > 7%
was statistically significant for
superficial wound infections (p =
0.044)

No

Level III

Retrospective analysis of
OPCAB (off pump
coronary artery bypass
surgery) patients and their
characteristics related to
sternal wound
complications

Higher HbA1C was significantly
associated with a higher incidence
of sternal wound complications
and a higher grade of
complication (grades 1-4, grade
3&4 are DSWI) p = 0.010

Yes

Level III

Level III

Note: Level of Evidence is based on the Johns Hopkins rating scale (Dang et al., 2022); *Did not specifically
evaluate DSWI as an outcome
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Table B2
Summary of Evidence for Post-Op Sternal Vest Use to DSWI in Cardiac Surgery Patients
Author &
Date

Albert et al.
(2019)

Brocki et al
(2009)

Caimmi et
al. (2017)

Celik et al.
(2011)

Study Outcomes

Supports
Use as a
Prevention
Measure

Level III

Posthoraxä vest use on
the second post-op day
after BIMA (bilateral
internal mammary artery)
grafting and median
sternotomy.

The early perioperative use of a
thorax stabilization vest, such as the
Posthoraxä vest, can reduce the
incidence of sternal wound
complications significantly.
Furthermore, when a wound infection
occurred, and the patient returned to
the hospital for wound revision,
patients who were given the
Posthoraxä vest postoperatively had
a significantly shorter length of stay
until wound closure

Yes – only
studied BIMA
grafts

Level V

Literature review on the
mechanical stress factors
causing sternal instability
and infection to create
evidence-based guidelines
for activity following
sternotomy.

Along with activity
recommendations, a supportive bra or
vest is recommended when breast cup
≥ D, body mass index ≥ 35 or
frequent coughing (reduces pain and
referenced the El-Ansary et al. (2008)
article on reducing sternal separation
in pts. with sternal instability

Yes –
literature
review

Level I

Posthoraxä vest used
following the removal of
the chest drains for the
entire hospitalization and
until 90 days after
discharge. Use is if they
have one identified risk
factor: diabetes, obesity
BMI >25, BIMA harvest,
COPD.

Statistically significant clinical
advantages were observed in the
group of patients that used the
Posthoraxä support vest following
sternotomy, such as fewer mechanical
complications, better sternal healing,
lower hospitalization, less pain and
lower analgesic medication
requirements, better comfort, and
earlier mobilization and autonomy.

Yes – did not
directly look
at DSWI, but
did show
better sternal
healing which
could impact
DSWI

Two studies were
performed on moderate to
severe COPD patients.
The second looked at
Postoperative thorax
support vest vs no vests.

Patients with a thorax support vest
had a significantly lower incidence of
dehiscence (1% vs 11.5%; P = .002)
and deep sternal wound infections
(0% vs 6.6%, P = .009); however, the
rates of superficial wound infections
(0% vs 2.5%, P = .253) and isolated
sternal dehiscence (1% vs 2.5%, P =
.628) were similar between the 2
groups. No deaths among the patients
who wore thorax support vests after
the operation, 35.7% of the patients
without a vest died.

Yes

Level of
Intervention/solution
Evidence

Level I
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Author &
Date

El-Ansary et
Level I
al. (2008)

Gorlitzer et
al. (2009)

Study Outcomes

Supports
Use as a
Prevention
Measure

Fifteen patients with sternal
instability more than 8 weeks
post onset were recruited for
the study. Four groups were
compared: sports tape,
compression garment,
adjustable fastening brace,
and non-intervention control.
They were then evaluated in a
series of upper-limb
movements.

Results from the implementation of a
set of supportive devices for patients
with chronic sternal instability
consistently favored the use of an
adjustable fastening brace, which
reduced the amount of sternal
separation by one fifth. Measures
tended to improve with the amount of
support offered by the device.

Yes – did not
directly look
at DSWI, but
did reduce
sternal
separation,
which could
impact
DSWI.

Evaluating effectiveness
of Posthoraxä vest.

Without sternal vest: sternal wound
complications developed in 4.9% with
DSWI at 1%, sternum dehiscence at
0.4%, and superficial sternal wound
complications at 1.3%. With the
sternum support vest: superficial
sternum complication was detected
0.6%. Of the those who refused the
vest: compilation rate at 9.4%,
including DSWI at 7.5% and
superficial wound problem at 1.9%.
These findings show highly
significant differences in sternal
complications between the groups

Yes

Level of
Intervention/solution
Evidence

Level I
(single
center)

Non-vest: total complications 3.87%,
dehiscence rate 0.77%, DSWI rate of
1.99%
Vest: total complications 0.61%, a
significantly lower incidence of
dehiscence at 0.046% and DSWI at
0.0001%.

Gorlitzer et
al. (2010)

Level I
(multicenter)

Evaluating effectiveness
of Posthoraxä vest.
Patients were advised to
wear the vest for at least
six weeks postoperatively

The occurrence of superficial wound
infections revealed no significant
difference (non-vest: 1.1% vs. vest:
0.6%). Hospitalization time including
complications was significantly
shorter in the vest group (14.76 days)
than in the non-vest group (17.33
days). No significant difference was
registered regarding ICU stay
between the patient groups (vest:
3.05; non-vest: 2.55"3). Mean
duration of the hospital stay was
extended to 59.6 days when a patient
required repeat surgery due to
instability or infection. In cases of
readmission during the follow-up
period, the mean hospital stay was
41.2 days.

Yes – an
intriguing
quote “The
economic
benefits of
shorter
hospital stays
and lower
rates of
reoperation
would
exceed, or at
least balance,
the additional
cost of vest
and
personnel.”
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Author &
Date

Gorlitzer et
al. (2013)

Klement et
al. (2016)

Tewarie et
al. (2012)

Tsang et al.
(2016)

Vos et al.
(2018)

Study Outcomes

Supports
Use as a
Prevention
Measure

Level I
(multicenter)

Evaluating effectiveness
of Posthoraxä vest.
Patients were instructed to
wear the vest
postoperatively for 24 h a
day for at least 6 weeks.
Patients who did not use
the vest within a period of
72 h postoperatively were
regarded as study dropouts

The frequency of DSWI was
significantly lower in vest at1.04% vs
non-vest at 2.27%, but superficial
complications did not differ between
groups. In the subgroup analysis, it
was found that patients who did not
receive, or refused to wear, the thorax
support vest were at higher risk for
deep sternal wounds.
Postoperatively, the non-compliant
group also had a prolonged intubation
time, a longer stay in the intensive
care unit, greater use of intra-aortic
balloon pump, higher frequency of
COPD and a larger percentage of
patients who required prolonged
surgery.

Yes –
consistent use
of the
Posthoraxä
vest
prevented
deep sternal
wounds

Level V

Case study of painful
sternal instability
following CABG with
male having a BMI of 40
and type 2 diabetes

Customized elastic vest of viscose
polyester flat knitwear with
compressing pressure worn for 3
months. Pain decreased within 4
weeks from 8/10 to 2-3/10, opioids
reduced, and sternum palpatory
stability

Yes - for
better sternal
stability,
which can
lead to lower
DSWI

Level I

Prospective randomized
study measuring the effect
of the use of a Stern-E-Fix
corset versus elastic thorax
band on sternal wound
infections

In the Stern-E-Fix group only
3.4% of patients developed sternal
wound infections compared to
9.5% in the elastic band group

Yes

Literature review on if
external support devices
reduce sternal wound
complications in patients
undergoing cardiac
surgery with sternotomy

In these studies, the Stern-E-Fix
corset was not evaluated in female
patients and a substantial population
found the Posthoraxä vest
uncomfortable and therefore refused
to wear it. But early post-sternotomy
use of the available external nonelastic sternal support devices reduces
sternal wound complications and may
be associated with a shorter length of
hospital stay

Yes –
literature
review

Literature review of RCTs
to assess interventions in
the prevention of DSWI

Referenced two RCTs being the
Twarie et al. (2012) & Gorlitzer et al.
(2013) articles on the impact of
postoperative chest support via corset
or vest. Both showed a significant
reduction in DSWI.

Yes

Level of
Intervention/solution
Evidence

Level V

Level V

Note: Level of Evidence is based on the Johns Hopkins rating scale (Dang et al., 2022)
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Table B3
Summary of Evidence for Vancomycin Paste to the Sternum Before Closure to DSWI in Cardiac
Surgery Patients
Author &
Date

Kowalski et
al. (2017)

Lazar et at.
(2014)

Magro &
Uva (2020)

Level of
Intervention/solution
Evidence

Level III
(metaanalysis)

Vancomycin on the
sternum, studies vary in
dose, and some are
bundled with additional
interventions

Level III

Vancomycin paste on
sternum. Compared
patients from 2007-2013
to patient from 2003-2007,
it has been commented on
that many things changed
in that many years that
could have improved
DSWI rates.

Level III

Servito et al.
Level I
(2021)

Study Outcomes

Three of four studies supported
that vancomycin paste decreased
DSWI, with an overall
significance of (p = 0.07).

Supports
Use as a
Prevention
Measure

*Yes

Vancomycin patients had
significantly fewer DSWI (p =
0.005)
Possibly a flaw in the study
design by using years previously
as a control group when other
practice changes could have been
in place.

Yes

Literature review

Conclusion was made that,
considering the body of evidence
available, topical antibiotic
application prevents SWI,
including both superficial and
deep SWI.

*Yes

Vancomycin-soaked
sponge applied to sternum
after opening versus saline
soaked sponge

At 3 months postoperatively,
there was no significant
difference in the incidence of SWI
between the vancomycin and
control groups (2.7% vs 4.1%: P
= 0.23). There was also no
significant difference between the
vancomycin and control groups in
the risk of superficial, deep, and
organ-space infections. Similar
findings were observed 1 year
postoperatively.

No

Note: Level of Evidence is based on the Johns Hopkins rating scale (Dang et al., 2022); * Denotes controversy
among researchers about the validity of the study
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Table B4
Summary of Evidence for Sternal Plating Closure Technique to DSWI in Cardiac Surgery
Patients
Author &
Date

Allen et al.
(2018)

Level of
Intervention/solution
Evidence

Level I

Ata & Beyaz
Level III
(2020)

Leinberger
et al. (2018)

Madjarov et
al. (2021)

Level I

Level III

Study Outcomes

Supports
Use as a
Prevention
Measure

Twelve US centers
randomized 236 patients
to either rigid plate
fixation (RPF) (n=116) or
wire cerclage (WC)
(n=120).

Trend towards fewer sternal
wound infections [0% (0/116) vs.
4.2% (5/120); P=0.06] The inhospital/30-day DSWI rate was
0% (0/116) with RPF compared
with 1.7% (2/120) with WC

Yes

Standard wire closure
(group 1) versus
preventative closure
techniques (group 2). A
handful of different
techniques were used

When comparing the groups, the
incidence of mediastinitis
significantly was lower in Group
2 (1.6% versus 0.45%, P = .004,
OR: 3.6, 95% CI: 1.52-8.82).
Preventive closure techniques
remarkably reduced mediastinitis,
but did not completely prevent it

*Yes

There is no statistically significant
difference between Sternal Talon
closure and wire cerclage in reducing
the incidence of mediastinitis and
superficial SSI after primary closure
of median sternotomy in high-risk
patients. Mediastinitis and/or sternal
instability within the
first 30 (5) days after the primary
sternum closure was
observed in 10 of 161 Sternal Talon
and 7 of 148 wire cerclage
patients of the FAS with known
status of end point (6.2 vs.
4.7%) OR was 1.3 (95% CI: 0.5–
3.6), p: 0.57.

*No

338 patients with elective
first median sternotomy
and at least four
predefined risk factors
were randomized between
Sternal Talon and wire
cerclage

319 high risk patients for
SWI and received
longitudinal rigid sternal
fixation, compared to 319
high risk patients who had
wire cerclage

Decreased rate of deep wound
infections (0.63% vs. 3.45%
vs., p < .01)

Yes
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Author &
Date

Level of
Intervention/solution
Evidence

Marzouk et
al. (2018)

1050 patient underwent
cardiac surgery via median
sternotomy and were
closed using rigid sternal
fixation (group A) (3
different techniques),
these patients were
matched with 1050 patient
who received conventional
transsternal wiring (group
B)

Matsuyama
et al. (2015)

Peigh et al.
(2017)

Royse et al.
(2020)

Tam et al.
(2018)

Level III

Study Outcomes
Decreased incidence of deep sternal
wound infection or dehiscence
among propensity score–matched
group A compared with group B
patients (1.9% vs 2.7%, p = 0.13),
although it was not statistically
significant.

No sternal wound dehiscence or
infections occurred, and no other
complications associated
with the plating system were
encountered

Level I

80 cardiac surgery
patients, 39 received rigid
plate fixation, 41 received
wire closure

One patient in Group R had a
deep sternal infection while no
patients in Group C had this
complication. (p = 0.3)

Level I

50 adult cardiac surgery
patients, 26 received
sternal plates, 24 received
figure of 8 wires

Level III

Meta-analysis of three
randomized controlled
trial studies and 5
observational studies to
compare rates of sternal
complications with rigid
plate fixation versus wire
cerclage

No

On multivariate analysis, group A
was associated with a 33% relative
risk reduction of deep sternal wound
infection or dehiscence (odds ratio,
0.67; 95% confidence interval, 0.480.94; p = 0.02)

64 patients underwent off
pump CABG (coronary
artery bypass grafting) by
the same surgeon, 31
received sternal plate
fixation, 33 received
conventional wire closure.
SternaLock plating system

Level III

Supports
Use as a
Prevention
Measure

No

Did not compare infection rate to
“control group;” looked at other
factors

No patient suffered a deep sternal
wound infection. (p = 1)

There was no significant
difference in sternal
complications with rigid plate
fixation at a median of 6 months’
follow-up (incidence rate ratio
0.51, 95% confidence interval
[CI]: 0.20 to 1.29, p = 0.15)
overall, but a decrease when
including only patients at high
risk for sternal complications
(incidence rate ratio 0.23, 95%,
CI: 0.06 to 0.89, p = 0.03; two
observational studies).

No

No

*Yes

Note: Level of Evidence is based on the Johns Hopkins rating scale (Dang et al., 2022); * Denotes
examination or support of high-risk patients only
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Table B5
Summary of Evidence for Post-Op Daily Chlorhexidine Baths to DSWI in Cardiac Surgery
Patients
Supports
Use as a
Prevention
Measure

Author &
Date

Level of
Intervention/solution
Evidence

Chien et al.
(2014)

Level III

For CABG pts. Infection
control care bundle (preop
chlorhexidine shower &
povidone iodine paint;
intra-op abx.; surgical
glove change after
harvests)

Incidence of DSWI decreased
from 2.3% to 0.7%. Incident of
SWI decreased from 3.4% to
1.4%. Incidence of MRSA SWI
decreased from 2.3% to 0.5%.

NA – did not
look at postop
chlorhexidine
Yes - for preop and glove
change

Level I

Plastic adhesive drape
versus bare skin; both
groups took 4%
chlorhexidine shower day
before surgery & morning
of surgery; chest & abd
.5% chlorhexidine solution
in 70% ethanol
disinfection

There were significantly higher
proportions of P. acnes- and
CoNS-positive skin cultures in
the adhesive drape group at 120
min compared with bare skin, and
significantly more CoNS-positive
subcutaneous cultures in the
adhesive drape group just before
skin closure.

NA - did not
specifically
look at postop
chlorhexidine

Level II

The control group
received routine care
consisting of shaving body
hair with a razor blade
followed by instructions to
take a bath or shower. In
the intervention groups,
patients received
education about surgical
site infection prevention
and body hair was
removed with an electric
clipper, followed by
bathing with daphne sap
containing olive oil or 2%
chlorhexidine solution

No significant differences in the
rate of sternotomy surgical site
infections among the three
groups.

NA – only
looked at
preop
chlorhexidine
use

FalkBrynhildsen
et al. (2013)

Karazeybek
et al. (2021)

Study Outcomes
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Author &
Date

Level of
Intervention/solution
Evidence

Kieser et al.
(2014)

Studied diabetic patients
and a subset of diabetic
women. Implemented a
protocol bundle: internal
thoracic artery (ITA)
skeletonization, no bone
wax, wound irrigation, 1
observer per case,
harmonic scalpel harvest
of ITAs, vancomycin paste
on sternal marrow, iodineimpregnated skin drapes,
chlorhexidine-alcohol skin
preparation, no BITA
grafts in obese pts., more
off-pump procedures,
aseptic wound care, and
marrow irrigation before
sternal approximation.

Kuhme et al.
(2007)

Madej et al.
(2016)

Level III

Level III

Level III

Prospective study where
cultures were taken periand postoperatively from
sternal wounds and skin to
investigate the degree of
bacterial contamination in
the sternal wound during
cardiac surgery and the
sternal skin flora after
operation to increase
understanding of the
pathogenesis of sternal
wound infections

Evaluate the effect of
combined ChloaPrepä
skin antiseptic on the
incidence of sternal
surgical incision infections
after cardiac surgical
procedures.

Study Outcomes

Supports
Use as a
Prevention
Measure

Achieved a significant reduction
in the incidence of DSWIs after
sequential introduction of
multiple infection prevention
measures. The most likely
contributors are the avoidance of
BITA grafts in obese diabetic
women and wound care protocol.

NA – did
implement a
bundle which
included
many risk
reduction
strategies
which made
for less DSWI

89% of the patients grew bacteria
from the subcutaneous sternal tissue.
98% of the patients showed bacterial
growth on the surrounding skin at the
end of the operation. Both
commensal and nosocomial bacteria
were found in the sternal wound.
There was no correlation between
length of operation and number of
bacteria. Men displayed higher
bacterial counts than women on the
skin. Surgeons have reason to treat all
‘‘clean wounds’’ in CV surgery as if
contaminated with bacteria normally
found in the skin. Skin preparation
with ethanol or chlorhexidine is
unable to suppress the physiological
skin flora for the duration of a heart
operation.

Skin disinfection with combined
chlorhexidine-isopropyl alcohol
reduced the incidence of
mediastinitis, but it did not affect
other types of surgical site
infections.

NA – did not
study
chlorhexidine
postop, but
did give
insight into
the flora
during the
case

NA – did not
study
chlorhexidine
postop
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Study Outcomes

Supports
Use as a
Prevention
Measure

At different time intervals,
prophylaxis with cefazolin
or vancomycin,
surveillance of sternal
SSIs and feedback, pre-op
nasal S. aureus screening
and decolonization with
mupirocin, isolation of
patients infected with or
colonized by MRSA,
appropriate management
of perioperative blood
glucose level and
chlorhexidine/alcohol
usage for skin antisepsis.

The most frequent causes of
sternal SSIs were coagulasenegative staphylococci (CoNS)
(36%) and S. aureus (31%).
Infection control interventions
reduced the rate of sternal SSIs
from 3.63% in 2005 to 1.65% in
2012. The rate of sternal SSIs can
be decreased with proper
infection control interventions.
However, the interventions that
were undertaken were effective
only in reducing the rate of
sternal SSIs caused by S. aureus.

NA – did not
look at postop
chlorhexidine

Literature review on
DSWI preventative
strategies.

Strategies to prevent DSWI
include pre-surgical cleaning with
clippers, pre-op bathing with
chlorhexidine scrub, nasal
mupirocin, screen for
hypoalbuminemia, smoking
cessation, weight reduction in
obese patients, peri-op antibiotics,
skeletonization of ITA grafts,
avoiding BITA, IV cefazolin and
implantable gentamycin-collagen
sponges, external chest support
devices, glycemic control, and
avoiding bone wax.

NA –
literature
review; did
not examine
post-op
chlorhexidine
use

Author &
Date

Level of
Intervention/solution
Evidence

Yavuz et al.
(2013)

Zia et al.
(2020)

Level II

Level V

Note: Level of Evidence is based on the Johns Hopkins rating scale (Dang et al., 2022);the terms
“Hibiclensâ” and “chlorhexidine” are used interchangeably, but the term “chlorhexidine” was the primary
term utilized
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Table B6
Summary of Evidence for Post-Op Surgical Bra Use to DSWI in Cardiac Surgery Patients
Author &
Date

Hummel &
Charlebois
(2020)

Rochon et
al. (2017)

Study Outcomes

Supports
Use as a
Prevention
Measure

The experience of 20 postcardiac surgery female
patients

Most women wore the surgical
support bra for one to three weeks
after surgery with 77% of
participants reporting that the bra
was helpful. 65% of participants
had difficulty with the surgical
support bra and 58% would
recommend the purchase of a
surgical bra to a peer.

No – did not
look at DSWI

BHIS (Brompton
Harefield Infection Scale)
bra use to reduce SSI
(surgical site infection)

348 study subjects matched of
BHIS and Non-BHIS support and
was observationally balanced.
The SSI risk was 2.3% (8/348)
versus 4.0% (14/348)
respectively; absolute risk
reduction 1.7% (Odds Ratio
0.5613, 95% CI 0.2324 to 1.3557.

Yes & No –
did not study
DSWI, but
just general
SSI

Level of
Intervention/solution
Evidence

Level III

Level V

Note: Level of Evidence is based on the Johns Hopkins rating scale (Dang et al., 2022)
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Table B7
Summary of Evidence for Intra-Op Sterile Glove Changes to DSWI in Cardiac Surgery Patients
Author &
Date

Bashir &
Sorensen
(2017)

Enz et al.
(2021)

Hosseini et
al. (2016)

Jurt et al.
(2021)

Level of
Intervention/solution
Evidence

Study Outcomes

Supports
Use as a
Prevention
Measure

Level II

Studied cerebrospinal fluid
shunt infections. Group A
without intraoperative
glove change and Group B
with change of the outer
pair of the initial double
gloves before handling the
shunt material. The results
were compared at 6- and
12-month postoperatively.

Intraoperative glove change does
not significantly reduce the risk of
shunt infection. However, it
seems to reduce the infection rate
within 6 months in patients
undergoing first-time shunt
insertion only

No

Level III

Studied general surgery
mechanical glove stress
and double gloving
effects.

The damage rate in low impact
procedures is high and represents
an underestimated problem in soft
tissue surgery. Double gloving
and glove change algorithms
should be established.

Yes –
including
double
gloving

Level III

Spinal operations bacterial
colonization if no glove
change or re-sterilization
occurred.

With a longer duration of surgery,
more colony-forming units are
recovered from gloved hands at
the end of surgery (R = 0.94, R2
= 0.89, p = 0.005). The receiveroperating characteristic curve
suggested that 5 hours is the
cutoff point for hand
recolonization. At 5 hours,
contamination reached or
exceeded prescrub levels (area
under the curve, 0.66; 95% CI,
0.23–1.0), whereas before 5
hours, there was no contamination
detected at the end of surgery.

Yes –
rescrubbing is
highly
recommended
before the fifth
hour of an
operation,
ideally at some
point between
the fourth and
fifth hours.

Level II

Multimodal SSI bundle for
colonic resections:
antibiotic type, timing, and
re-dosing; disinfection;
induction temperature
control > 36.5◦ ; glove
change; intra-cavity
lavage; wound protection;
and closure strategy

The implementation of an
intraoperative standardized care
bundle had no impact on SSI
rates. This may be explained by
insufficient compliance with the
individual measures.

No
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Author &
Date

Kim et al.
(2019)

Kobayashi
et al. (2020)

Kozon et al.
(2017)

Narice et al.
(2021)

Study Outcomes

Supports
Use as a
Prevention
Measure

Systematic review on
Arthroplasty surgeries
about SSI and PJI
(prosthetic joint
infections).

As microbiological contamination
rates of gloves increase with
duration of surgery, glove
changes are recommended at least
once per hour. Furthermore,
gloves should be changed after
draping, before handling implants
and if visible perforation is seen
to reduce contamination.

Yes – hourly

Level III

Gastrointestinal surgery
incidence of glove
perforation to reduce the
risk of blood and body
fluid exposure

The inner gloves and outer gloves
have a higher perforation rate as
the wear time increased. To
reduce the risk of intraoperative
blood and fluid exposure and
prevent healthcare-associated
infection, gloves should be
changed for approximately every
60–90 min for outer gloves and
approximately every 240 min for
inner gloves.

Yes – q60-90
min for outer
gloves and
q240min for
inner, but did
not directly
look at SSI

Level II

Two groups of 30 patients
underwent primary CIED
(cardiac implantable
electronic device)
implantation or
replacement. Before the
device entered the surgical
field, surgeon and assistant
imprinted their outer
gloves on aerobe and
anaerobe agar plates, and a
wound swab was
performed. Samples were
cultured, and the presence
of bacteria was identified

Contamination of gloves is
common during CIED procedures
before handling the device.
Therefore, devices are often
handled with contaminated
gloves. The most prevalent
bacteria were PS and CNS, which
are associated with clinical CIED
infections. Changing outer gloves
before handling the device might
improve sterile state and lower
infection risk.

Yes – did not
directly test
glove
changes, but
the practice
could be
deduced
based on the
findings

Level I

Systematic review and
meta-analysis of RCTs
aimed to assess the impact
of changing gloves
intraoperatively on postcesarean section infective
morbidity

Changing gloves during a
cesarean section was associated
with a statistically significantly
lower incidence of wound
infective complications

Yes

Level of
Intervention/solution
Evidence

Level II
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Author &
Date

Palo et al.
(2017)

Rehman et
al. (2015)

Scrafford et
al. (2018)

Tlili et al.
(2018)

Level of
Intervention/solution
Evidence

Study Outcomes

Supports
Use as a
Prevention
Measure

Level II

Multicenter: Group 1,
surgical team operated
with regular changing of
gloves. In Group 2, only 1
set of double gloves were
worn throughout the
procedure. Surgical
parameters or clinical
outcomes were assessed
for both the groups.

Glove contamination rate in
Group-2 was 0.2%. Outer glove
perforation rate of 5.85% in
Group-1 and 8.15% in Group-2.
Under standard operating
conditions, procedures performed
without glove change are shorter
and cost effective than procedures
performed with regular glove
change with similar surgical and
functional results.

No

Level II

Spinal surgery infection
study. A control group
treated with standard
protocol for the procedure
(group A) and a treatment
group where after initially
double gloving, the outer
pair of gloves was
removed before handling
the instrumentation.
Infection rates were
compared up to 1 year
postoperatively

There was a statistically
significant reduction of infection
rate from 3.35% in group A
(control) to 0.48% in group B.
The removal of an outer pair of
gloves before handling
instrumentation may be a simple,
cost effective, and practical way
to reduce the burden of
postoperative infection following
lumbar spinal fusion.

Yes – double
gloving and
initial outer
pair changed
before
handing
instruments

Level I

Women undergoing a Csection were randomized
to usual care or intraoperative glove-changing
prior to abdominal closure.

Intraoperative glove changing led
to a significant decrease in
composite wound complications
from 13.6% in the control group
to 6.4% in the intervention group.
Intra-operative glove changing
prior to abdominal closure during
cesarean section significantly
reduced the incidence of postoperative wound complications.

Yes – before
closure

Level III

3 different surgical
departments: urology,
maxillofacial, and general
and digestive. The gloves
were collected and tested
to detect perforations
using the water leak test

Perforated gloves were at a rate of
16.5%. All perforations were
unnoticed by the surgical team
members. The findings reaffirm
the importance of double-gloving
and changing gloves in surgeries
of more than 90 minutes duration.

Yes – double
glove and
q90min
changes
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Author &
Date

Ward et al.
(2014)

Level of
Intervention/solution
Evidence

Level II

Surgical team members
were randomized to
exchange or retain outer
gloves 1 hour into clean
orthopedic procedures;
cultures were obtained 15
minutes later from the
palm of the surgeon’s
dominant gloved hand.

Study Outcomes

Surgeons retaining outer gloves 1
hour into the case had a
subsequent positive glove
contamination rate of 23%
compared with 13% among
surgeons exchanging their
original outer glove

Note: Level of Evidence is based on the Johns Hopkins rating scale (Dang et al., 2022)

Supports
Use as a
Prevention
Measure

Yes – one
hour into
surgical case
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Appendix C
Detailed Analysis of Included HbA1C Articles
Author
& Date
Bardia et
al. (2017)

Corazzari
et al.
(2021)

Purpose

Population,
Size, &
Setting

Study Type
Variables/
& Level of Intervention/
Evidence
Measures

To discover if
preoperative
HbA1C can
identify
patients at
greater risk for
major adverse
events (MAE)
and if post-op
glycemic
variability is
correlated with
MAE after
cardiac valve
surgery

N = 763 Adults
undergoing
isolated valve
surgery
n = 109 patients
with a HbA1C
greater than or
equal to 6.5%
n = 654 patients
with a HbA1C >
6.5%
Beth Israel
Deaconess
Medical Center

Observational
cohort study

To identify
studies that
examined the
relationship
between
glycosylated
hemoglobin
and clinical
outcomes in
cardiac
surgery

30 studies,
34,650 patients

Systematic
review and
meta-analysis

Independent
variable:
HbA1C

Level III
Dependent
variable: MAEs,
including sternal
infection

Level III

Independent
variable:
hemoglobin
A1C,
dependent
variable: sternal
wound
infections

Results

Findings That
Help Answer the
EBP Question

Limitations &
Notes

There was no
significant
association
between
preoperative
HbA1C and MAEs

HbA1C does not
predict the risk of
DSWI in valve patients

MAEs were extracted
from STS database
and included sternal
infection, restricted to
patients with HbA1C
measured

HbA1C < 7.5%
was associated
with a lower risk of
sternal wound
infections (p =
0.003)
HbA1C < 7% was
associated with a
lower risk of
sternal wound
infections (p <
0.0001)

Reducing HbA1C prior
to surgery is advised to
decrease risk for
negative post-operative
outcomes

Did not differentiate
between deep sternal
wound infections and
superficial wound
infections.
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Author
& Date
Gatti et al.
(2017)

Halkos et
al.
(2008a)

Halkos et
al.
(2008b)

Purpose

Population,
Size, &
Setting

Study Type
Variables/
& Level of Intervention/
Evidence
Measures

To investigate
elevated
HbA1C level
and its impact
on sternal
wound
infections in
CABG
patients

N = 2,130
patients from
the E-CABG
registry which
includes
patients from 16
European
centers of
cardiac surgery

Observational

To discover if
preoperative
HbA1C is
predictive of
DSWI after
bilateral
internal
thoracic artery
grafting

N = 5,199
patients
undergoing
isolated CABG
who had a
baseline HbA1C
drawn and at
least one
internal thoracic
artery graft

Retrospective

To discover if
HbA1C is a
predictor of
adverse
outcomes after
CABG

N = 3,089 pts.
undergoing
elective CABG
and had
preoperative
HbA1C level
obtained at
Emory
University
Hospital, Emory
Crawford Long
Hospital, and
Wellstar
Kennestone
Hospital

Retrospective

Level III

Independent
variable:
HbA1C
Dependent
variable: sternal
wound
infections

Level III

Independent
variable:
HbA1C
Dependent
variable: deep
sternal wound
infections

Level III

Independent
variable:
HbA1C
Dependent
variable: deep
sternal wound
infections

Results

Findings That
Help Answer the
EBP Question

Limitations &
Notes

Preoperative
HbA1C was
significantly higher
is patients with
sternal wound
infection (p <
0.0001)

Elevated HbA1C is
associated with sternal
wound infections in
CABG patients, didn’t
single out DSWI

HbA1C > 8.6% was
associated with the
highest risk of sternal
wound infection,
sternal wound
infections were
graded based upon
CDC definitions

Patients
undergoing BITA
grafting with a
HbA1C > 7% had
a greater incidence
of DSWI (p =
0.014) For each
unit increase in
HbA1C, there was
a 31% increased
risk of DSWI

When patients are
considered for BITA
grafting, HbA1C
should be measured
and considered a risk
for DSWI

DSWI defined by
STS

CABG patients
with a HbA1C >
7% were at
significantly
increased risk for
DSWI (p = 0.007)

Elevated HbA1C is
strongly associated
with adverse events in
patients undergoing
CABG

HbA1C > 8.6% is
associated with a 4
fold risk in mortality
Of note, 4.9% of
patients
with no history of
diabetes had HbA1c
levels of
7% or greater

For each unit
increase in HbA1C
the risk for DSWI
is significantly
increased
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Author
& Date
Khan et
al., (2019)

Kim et al.,
(2020)

Purpose

Population,
Size, &
Setting

Study Type
Variables/
& Level of Intervention/
Evidence
Measures

To assess the
association
between
preoperative
HbA1C and
post-operative
mortality,
infections,
pneumonia,
and sepsis

N = 1,113
patients
undergoing
isolated CABG
N = 315 patients
with HbA1C >
7%

Retrospective
cohort study

Evaluate the
impact of
preoperative
HbA1C in
patients with
diabetes
undergoing
off-pump
coronary
artery bypass
surgery on
glycemic
variability and
short-term
outcomes

N = 703 patients
who underwent
off-pump
coronary artery
bypass surgery
n = 287 patients
with HbA1C <
7%
n = 416 patients
with HbA1C
greater than or
equal to 7%

Retrospective

Independent
variable:
HbA1C

Level III
Dependent
variable: sternal
wound
infections

Level III

Independent
variable:
HbA1C
Dependent
variable: DSWI

Results

Findings That
Help Answer the
EBP Question

Limitations &
Notes

No statistically
significant
association was
found between
HbA1C and postoperative infection
(p > 0.999)

HbA1C is not
associated with sternal
wound infections in
CABG patients

Superficial and deep
sternal wound
infections not
differentiated
between.

DSWI occurred
significantly more
frequently in
patient with a
HbA1C > 7% (p =
0.019)

Preoperative HbA1C >
7% is a risk factor for
adverse outcomes in
cardiac surgery

Used STS definition
of DSWI
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Author
& Date
Narayan
et al.,
(2017)

Purpose
To determine
if elevated
HbA1C is
associated
with adverse
outcomes for
patients
undergoing
elective
CABG

Population,
Size, &
Setting
N = 4,678
patients with
elective CABG
at a single
institution

Study Type
Variables/
& Level of Intervention/
Evidence
Measures
Retrospective
observational
study

Independent
variable:
HbA1C
Dependent
variable: DSWI

Results
HbA1C > 6.5% is
associated with a
significant increase
in DSWI.

Findings That
Help Answer the
EBP Question

Limitations &
Notes

HbA1C > 6.5% is
associated with a
significant increase in
DSWI.

Used STS definition
of DSWI

HbA1C > 7% is a risk
factor for DSWI.

Used CDC definition
of DSWI

(p = 0.015)

n = 2,476
patient with
HbA1C < 6.5%
n = 2,202
patients with
HbA1c greater
than or equal to
6.5%

Nicolini
et al.,
(2018)

Does HbA1C
when used as a
predictor of
glycemic
control,
predict
adverse events
after cardiac
surgery

N = 2,606
patients
undergoing
elective isolated
CABG from the
E-CABG
registry which
includes
patients from 16
European
centers

Prospective,
cohort study

Independent
variable:
HbA1C

Level III
Dependent
Variable: DSWI

HbA1C > 7% was
a significant
predictor of DSWI
(p = 0.001)
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Author
& Date
Ramadan
et al.,
(2017)

Van de
Eynde et
al. (2021)

Purpose

Population,
Size, &
Setting

Study Type
Variables/
& Level of Intervention/
Evidence
Measures

To determine
if hemoglobin
A1C is a risk
factor for
adverse
outcomes in
cardiac bypass
surgery.

N = 80 patients
undergoing
CABG surgery
at the National
Heart Institute
n = 40 patients
with a HbA1C
less than or
equal to 7%, n =
40 patients with
a HbA1C
greater than 7%

Correlational
research

To investigate
the association
between
HbA1C and
preoperative
glycemia in
patients
undergoing
off-pump
coronary
artery bypass
surgery

N = 1774 off
pump coronary
artery bypass
surgery patients

Retrospective

University
Hospitals of
Leuven

Independent
variable:
HbA1C value

Level III
Dependent
variable: wound
infections, renal
failure,
mortality

Level III

Independent
variable”
HbA1C
Dependent
variable: sternal
wound
complications

Results

Findings That
Help Answer the
EBP Question

Limitations &
Notes

HbA1C was not
found to be a
significant risk
factor for DSWI (p
= 0.152), HbA1C
was found to be a
significant risk
factor for
superficial wound
infection (p =
0.044)

Hemoglobin A1C is a
good predictor of
morbidity and worth
the time and effort to
decrease it below 7%
to decrease
postoperative
complications.

Only first-time
sternotomies, the
higher HbA1C group
had a significantly
lengthier hospital stay

A higher HbA1C
was significantly
associated with a
greater incidence
of sternal wound
complications (p =
0.016) and a higher
grade of sternal
wound
complications (p =
0.010)
HbA1C was found
to be significantly
different between
patients with a
SWI and those
without (p = 0.007)

Elevated HbA1C is
significantly associated
with an increased
incidence and higher
grade of sternal wound
infection

This article graded
sternal wound
complications into 4
grades, DSWI would
fall under grades 3
and 4.

Note: Level of Evidence is based on the Johns Hopkins rating scale (Dang et al., 2022) Adapted from “Johns Hopkins evidence-based practice model for
nursing and healthcare professionals: Individual Evidence Summary Tool (Appendix G),” by Johns Hopkins Health System/Johns Hopkins School of
Nursing, 2021. Copyright 2021 by Johns Hopkins Health System/Johns Hopkins School of Nursing.
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Appendix D
Detailed Analysis of Included Sternal Vest Articles
Author
& Date
Albert et
al. (2019)

Brocki et
al. (2010)

Purpose

Population,
Size, &
Setting

Study Type
& Level of
Evidence

Variables/
Intervention/
Measures
Independent
variable:
Posthoraxä vest

To compare
wound
complications
after bilateral
internal mammary
artery (BIMA)
grafting with and
without the use of
the Posthoraxä
vest.

N = 3,280 patients
who underwent
coronary artery
revascularization
using BIMA
n = 1613 patients
undergoing
BIMA who used
the Posthoraxä
vest postop
n = 1,667 patients
undergoing
BIMA who did
not use the
Posthoraxä vest
postop

Retrospective
cohort study

To identify
mechanical stress
factors causing
sternal instability
and infection to
create evidencebased guidelines
for activity
following
sternotomy

Did not note how
many articles
were found or
their levels of
evidence within
the review

Literature
review

Level III

Dependent
variable: sternal
wound
complications

Level V

Aim: to identify
mechanical
stress factors that
may be
associated with
sternal
dehiscence, pain,
and infection to
create evidencebased guidelines
for activity

Results

Findings That
Help Answer the
EBP Question

Sternal wound
complications
occurred
significantly more
frequently in
patients who did
not use the
Posthoraxä vest
(p = 0.036)

Early use of the
Posthoraxä vest can
decrease sternal wound
complications

A supportive bra
or vest is
recommended
when breast cup is
greater than or
equal to D, and
when BMI is
greater than 35;
Patients with BMI
≥ 35 should wear a
supportive vest for
sternal protection
during the initial
6–8 weeks.

Supportive vest is
recommended for 6-8
weeks post-op, but the
level of evidence for
this recommendation is
just based on expert
opinion (Level V).

Applied vest on second
post-op day and worn
for eight weeks after
discharge

Limitations
& Notes
Does not define
wound
complication
Large sample
size, but only
studied BIMA
approach
Setting not
disclosed

Use of a sternal
vest is based on
expert opinion
Did not note
how many
articles were
found or their
levels of
evidence within
the review
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Author
& Date
Caimmi et
al. (2017)

Purpose
To investigate the
role of the
Posthoraxä vest in
the prevention of
sternal
complications and
healing of patients
at high risk for
sternal dehiscence
after median
sternotomy

Population,
Size, &
Setting
N = 310 patients
with risk factors
for sternal
dehiscence after
cardiac surgery
with sternotomy

Study Type
& Level of
Evidence

Variables/
Intervention/
Measures

Prospective
randomized
study

Independent
variable:
Posthoraxä
support vest

Level I

Dependent
variables: sternal
healing, length
of hospital stay,
reoperation for
dehiscence
before discharge

N = 155 patients
used the
Posthoraxä vest
N = 155 patients
didn’t use the
Posthoraxä vest

Results

Findings That
Help Answer the
EBP Question

Sternal separation
> 2mm at
discharge was
significantly more
likely in the no
Posthoraxä group
(p = 0.005)

Patients using the vest
demonstrated better
sternal healing with a
lower incidence of
mechanical sternal
complications

Of the patients that
received the
Robicsek sternal
closure technique,
those that also
utilized a sternal
support vest after
surgery had a
significantly lower
rate of sternal
dehiscence (p =
0.002)

COPD is a risk factor
for sternal dehiscence
and sternal support
vests help to prevent
sternal dehiscence

Vest initiated after all
chest tubes were
removed and up until
90 days after discharge

Limitations
& Notes
Setting not
disclosed
Use of the
Posthoraxä
vest during the
90 days after
discharge was
difficult to
track and relied
upon patient’s
report

Setting not
disclosed
Celik et
al. (2011)

To determine
whether moderate
and severe chronic
obstructive
pulmonary disease
(COPD) is a
significant risk
factor in sternal
dehiscence, and if
the Robicsek
technique for
sternal closure
with the use of a
sternal support
vest after surgery
would reduce
sternal dehiscence.

Study 1 N = 842
patients
undergoing
cardiac surgery
using figure of 8
wire closure
Study 2 N = 221
patients
undergoing
cardiac surgery
using the
Robicsek sternal
closure technique
Medicanas
Hospital Group in
Istanbul, Turkey

Retrospective
for Study 1,
Randomized
control trial for
Study 2
Level III
And
Level I
The sternal
support vest
was compared
in Study 2

Independent
variables:
closure
technique,
sternal support
vest, COPD
Dependent
Variables:
sternal
dehiscence

No information on
when during post-op
the vest was initiated
and for how long it
was worn

Only studied
patients with
COPD
The Robicsek
sternal closure
technique was
used for all
patients in the
sternal support
vest
comparison
study
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Author
& Date
El-Ansary
et al.
(2008)

Purpose
To evaluate the
effect of three
supportive devices
on sternal
separation.

Population,
Size, &
Setting

Study Type
& Level of
Evidence

Variables/
Intervention/
Measures

N = 15 patients
with sternal
instability after
median
sternotomy

Crosssectional
randomized
intervention
study

Setting not
disclosed

Level I

Independent
variables: sports
tape,
compression
garment,
adjustable
fastening brace

Results
An adjustable
fastening brace
when compared to
no support closed
the sternal gap by
20%

Sternal support devices
aid in reduction of
sternal separation and
pain

Sternal wound
complications
occurred
significantly more
frequently in the
group that did not
use the vest (p =
0.0152) 7 DSWI
occurred in the no
vest group and
none in the vest
group

Posthoraxä sternal
support vest prevents
sternal instability after
cardiac surgery

Dependent
variable: sternal
separation,
patient selfreport pain

Gorlitzer
et al.
(2009)

To evaluate the
effectiveness of
the Posthoraxä
sternum vest

N = 455 patients
undergoing
cardiac surgery

Prospective
randomized
study

n = 175 patients
utilized the vest
n = 227 did not
utilize the vest

Level I

Setting not
disclosed

Independent
variable:
Posthoraxä
support vest
Dependent
variable: sternal
complications

Findings That
Help Answer the
EBP Question

Vest was studied on
patients that were more
than 8 weeks post-op
when sternal instability
was already present
and not worn
continuously

No DSWI present in
the Posthoraxä group
Vest placed within 24
hours of operation, but
did not disclose for
how long the vest was
worn

Limitations
& Notes
Very small
sample size
Setting not
defined, just
noted patients
from the
general
community
with sternal
instability more
than 8 weeks
post-onset

“Sternal wound
complications”
are not defined
25% of wound
infections
occurred after
discharge
supporting
monitoring for
90 days post-op
Setting not
disclosed

109

Author
& Date
Gorlitzer
et al.
(2010)

Purpose
To determine the
effect of the
Posthoraxä
support vest after
median
sternotomy

Population,
Size, &
Setting
N = 1,560
n = 905 received a
flexible dressing
postoperatively
n = 655 received a
Posthoraxä
support vest

Study Type
& Level of
Evidence

Variables/
Intervention/
Measures

Prospective
randomized
multicenter
trial

Independent
variable:
Postoraxä
support vest

Level I

Dependent
variable:
reoperation rates,
dehiscence,
superficial
sternal wound
infection, DSWI

Multicenter

Gorlitzer
et al.
(2013)

To assess the
effectiveness of
the Posthoraxä
support vest to
prevent sternal
wound infections
after cardiac
surgery

N = 2,539 patients
undergoing
cardiac surgery by
median
sternotomy
n = 1,351
Posthoraxä
support vest
patients
n = 1,188 no
intervention
patients

Prospective,
randomized,
multi-center
trial
Level I

Independent
variable:
Posthoraxä vest
us for 24 hours a
day for six
weeks, starting
48 hours after
surgery

Results

Findings That
Help Answer the
EBP Question

Reoperation rates
were significantly
lower in the
Posthoraxä group
(p < 0.05)
There were
significantly
higher rates of
DSWI in the nonvest group (p <
0.0001)

Posthoraxä sternal
support vest can help
prevent sternum
related complications
after cardiac surgery

The Posthoraxä
group had
significantly less
DSWI (p < 0.01)

Consistent use of the
Posthoraxä vest after
cardiac surgery can
help prevent sternal
wound infections

Vest was applied 48
hours after surgery
(usually after their ICU
stay) and advised to be
worn for at least 6
weeks post-op

Vest was applied 48
hours after surgery
(usually after their ICU
stay) and advised to be
worn for at least 6
weeks post-op

Dependent
variable: deep
sternal wound
infections

Limitations
& Notes
Large sample
size and
multicenter
Did not report
compliance
statistics

Large sample
size and
multicenter
202 refused to
wear the vest,
216 did not
wear vest for
other reasons

Multicenter
Klement
&
Herrmann
(2010)

To offer an
alternative option
to surgery for
sternal non-union.

N =1 A 74-yearold male with
sternal instability
following aortic
valve replacement
and CABG
Setting not
disclosed

Case study
Level V

Independent
variable:
compression
garment vest
Dependent
variable: sternal
healing and pain

After three months
CT showed
complete osseous
wound healing

Compression vests
may be helpful in
sternal healing after
cardiac surgery with
sternotomy

Setting not
disclosed.
Lower level-ofevidence due to
it being a case
study
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Author
& Date
Tewarie et
al. (2012)

Tsang et
al. (2016)

Purpose
To determine the
effect of the sterne-fix corset on
ternal instability
and mediastinitis
in high-risk
patients

To discover if
external support
devices reduce
sternal wound
complications
after cardiac
surgery with
median
sternotomy.

Population,
Size, &
Setting
N = 750 male
patients
undergoing
cardiac surgery
with median
sternotomy
n = 380 wore
Stern-E-Fix corset
for 6 weeks
postop
n = 370 received
standard elastic
thorax band
Setting not
disclosed
6 randomized
control trials with
5,826 patients
were included

Study Type
& Level of
Evidence

Variables/
Intervention/
Measures

Prospective
randomized
study

Independent
variable: stern-efix corset

Level I

Dependent
variable: sternal
instability,
mediastinitis

Results
In the stern-e-fix
group only 3.4%
of patients
developed sternal
wound infections
compared to 9.5%
in the elastic band
group

Findings That
Help Answer the
EBP Question
Use of the Stern-E-Fix
corset can help to
decrease sternal wound
infections after cardiac
surgery
Only high-risk patients
received the corset
Corset was initiated on
first post-op day and
until 6 weeks post-op

Literature
review

Limitations
& Notes
Only male
patients
studied, sternal
wound
infection
defined by
CDC
Setting not
disclosed

Independent
variable: sternal
support device

Early use of a non- Use of non-elastic
Substantial
elastic sternal
sternal support devices number of
support device
should be considered
patients
Level V
post-sternotomy
reported the
Dependent
reduces sternal
Posthoraxä
variable: sternal
wound
vest was
would
complications and
uncomfortable
complication,
may reduce length
and refused to
length of
of stay in the
wear it
hospital stay
hospital.
Vos et al.
To review RCTs
734 total articles
Literature
Independent
Stern-E-Fix and
Utilizing the 2 RCTs
Included the
Twarie et al.
(2018)
to assess
found; 48 RCTs
review
variable: sternal
included, the use of a
Posthoraxä both
(2012) &
interventions to
selected
support device
showed significant sternal support device
Gorlitzer et al.
prevent DSWI
Level V
reduction in DSWI significantly reduces
(2013) articles
2 RCTs related to
Dependent
DSWI
(p = 0.000 & p =
the DSWI topic
variable: DSWI
0.017,
respectfully)
Note: Level of Evidence is based on the Johns Hopkins rating scale (Dang et al., 2022). Adapted from “Johns Hopkins evidence-based practice model for

nursing and healthcare professionals: Individual Evidence Summary Tool (Appendix G),” by Johns Hopkins Health System/Johns Hopkins School of
Nursing, 2021. Copyright 2021 by Johns Hopkins Health System/Johns Hopkins School of Nursing.
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Appendix E
Likert Patient Evaluation Discharge Survey for Posthoraxä
PRODUCT VALUE ANALYSIS
Evaluation Form - Patients
INSTRUCTIONS: Please complete this form prior to discharge and give to your RN, PCA, or Unit HUC
PRODUCT: Posthoraxä Sternal Support Vest
MANUFACTURER: Posthorax, Inc.
ITEM NUMBER: 10.1202-10.1205; 11.1202-1205
QUALITY: Durability,
comfort, enhanced care
delivery

Very
Satisfactory
(5)

Satisfactory
(4)

Neutral
(3)

Unsatisfactory
(2)

Very
Unsatisfactory
(1)

Very
Satisfactory
(5)

Satisfactory
(4)

Neutral
(3)

Unsatisfactory
(2)

Very
Unsatisfactory
(1)

Very
Satisfactory
(5)

Satisfactory
(4)

Neutral
(3)

Unsatisfactory
(2)

Very
Unsatisfactory
(1)

1.-Fabric comfort and
durability
2.-Fasteners ease of use and
comfort
3.-Other (Please comment)
EFFECTIVENESS: How
well the product meets its
intended purpose
1.-Overall pain control
2.-Ability to use your
Incentive Spirometer or take
deep breaths and cough while
wearing vest
3.-Overall sternal/chest wound
healing
4.-Other (Please Comment)
OPERATION: Ease of Use
1.-Putting the vest on
2.- Activity/Mobility in vest
3.-Taking the vest off
4.-Other (Please Comment)

**Product Value Analysis Continued on Back of Page**
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SAFETY: Unwanted or
harmful effects

Very
Satisfactory
(5)

Satisfactory
(4)

Neutral
(3)

Unsatisfactory
(2)

Very
Unsatisfactory
(1)

Very
Satisfactory
(5)

Satisfactory
(4)

Neutral
(3)

Unsatisfactory
(2)

Very
Unsatisfactory
(1)

1.-Interference with tubes,
lines?
2.-Pressure points on your
skin?
3.- Other (Please Comment)
OTHER: Other issues to
consider
1.2.Would you recommend that Mayo continues to use this product?

Comments:

Thank You for Completing This Form

YES _____
NO ______
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Appendix F
Draft Letter and Likert Patient Evaluation 6-Week Survey for Posthoraxä

Date:

7/20/2022

From:

Department of Cardiac Surgery

Re:

Deep Sternal Wound Infection Prevention, Posthorax support vest implementation

To:

[Name of Patient]

Dear [name of patient],
You recently underwent cardiac surgery at the Mayo Clinic and utilized a
Posthoraxä sternal support vest. This letter includes a survey to gather information on your
satisfaction with the vest. Your input is anonymous, valued, and will be utilized to improve
future patient experiences with the vest. Please fill out the survey and return it with the prepaid
envelope provided. If you utilize Mayo’s Portal, this survey has also been sent there
electronically; you only need to fill out this paper form or the electronic form, not both. If you
would like to speak to someone about your experience with the Posthoraxä sternal support vest,
please e-mail Ben Hickox, APRN, CNS, D.N.P. at Hickox.Benjamin@mayo.edu, Sam Porcher,
RN at Porcher.Samantha@mayo.edu, or Cole Gatzke, RN, at Gatzke.Cole@mayo.edu.

Sincerely,
The Department of Cardiac Surgery
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PRODUCT VALUE ANALYSIS
Evaluation Form - Patients
INSTRUCTIONS: Please complete this form after completing 6-weeks of wearing the vest and return to Mayo
Clinic via stamped, paid envelope provided. If any questions or further comments arise, please contact those
listed in the included letter.
PRODUCT: Posthoraxä Sternal Support Vest
MANUFACTURER: Posthorax, Inc.
ITEM NUMBER: 10.1202-10.1205; 11.1202-1205
QUALITY: Durability,
comfort, enhanced care
delivery

Very
Satisfactory
(5)

Satisfactory
(4)

Neutral
(3)

Unsatisfactory
(2)

Very
Unsatisfactory
(1)

Very
Satisfactory
(5)

Satisfactory
(4)

Neutral
(3)

Unsatisfactory
(2)

Very
Unsatisfactory
(1)

Very
Satisfactory
(5)

Satisfactory
(4)

Neutral
(3)

Unsatisfactory
(2)

Very
Unsatisfactory
(1)

1.-Fabric comfort and
durability
2.-Fasteners ease of use and
comfort
3.-Other (Please comment)
EFFECTIVENESS: How
well the product meets its
intended purpose
1.-Overall pain control
2.-Ability to use your
Incentive Spirometer or take
deep breaths and cough
3.-Overall sternal/chest wound
healing
4.-Other (Please Comment)
OPERATION: Ease of Use

1.-Putting the vest on
2.- Activity/Mobility in vest
3.-Taking the vest off
4.-Other (Please Comment)

**Product Value Analysis Continued on Back of Page**
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SAFETY: Unwanted or
harmful effects

Very
Satisfactory
(5)

Satisfactory
(4)

Neutral
(3)

Unsatisfactory
(2)

Very
Unsatisfactory
(1)

Very
Satisfactory
(5)

Satisfactory
(4)

Neutral
(3)

Unsatisfactory
(2)

Very
Unsatisfactory
(1)

1.-Interference with tubes,
lines?
2.-Pressure points on your
skin?
3.- Other (Please Comment)
OTHER: Other issues to
consider
1.2.Would you recommend that Mayo continues to use this product?

Comments:

Thank You for Completing This Form

YES _____
NO ______

116
Appendix G
Likert Staff Evaluation Survey for Posthoraxä
Consent Waiver
The completion and submission of this evaluation survey indicated implied consent to the use its
contents for data analysis and dissemination. No personal identification data is collected, nor will
be utilized for the purposes of this evaluation. Participation involves no more than minimal risk
and will not adversely affect your rights and welfare. Overall evaluation analysis will be
disseminated to staff through this project members and unit leadership once completed.
PRODUCT VALUE ANALYSIS
Evaluation Form - Staff
INSTRUCTIONS:

Please complete this form and return to Ben Hickox, CNS Office: Mary Brigh 5-590. This survey is anonymous, and
responses will be used to determine if Mayo Clinic should continue to use the Posthoraxä vest and what other improvements could be made.

PRODUCT: Posthoraxä Sternal Support Vest
MANUFACTURER: Posthoraxä Inc.
ITEM NUMBER: 10.1202-10.1205; 11.1202-1205
QUALITY: Durability,
reliability, integrity, enhanced
care delivery

Very
Satisfactory
(5)

Satisfactory
(4)

Neutral
(3)

Unsatisfactory
(2)

Very
Unsatisfactory
(1)

Very
Satisfactory
(5)

Satisfactory
(4)

Neutral
(3)

Unsatisfactory
(2)

Very
Unsatisfactory
(1)

1.-Fabric
2.-Fasteners
3.-Other (Please comment)
EFFECTIVENESS: How
well the product meets its
intended purpose
1.-Reducing pain
2.- Improved Participation in
Incentive Spirometry/Deep
Breathing-Coughing
3.- Prevents Wound
Dehiscence
4.-Other (Please Comment)

**Product Value Analysis Continued on Back of Page**
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OPERATION: Ease of Use

Very
Satisfactory
(5)

Satisfactory
(4)

Neutral
(3)

Unsatisfactory
(2)

Very
Unsatisfactory
(1)

Very
Satisfactory
(5)

Satisfactory
(4)

Neutral
(3)

Unsatisfactory
(2)

Very
Unsatisfactory
(1)

Very
Satisfactory
(5)

Satisfactory
(4)

Neutral
(3)

Unsatisfactory
(2)

Very
Unsatisfactory
(1)

1.-Donning (Putting vest on
patient)
2.- Patient Cares/Mobility
3.-Doffing (Taking vest off
patient)
4.-Other (Please Comment)
SAFETY: Unwanted or
harmful effects
1.-Interference with tubes,
lines?
2.- Pressure points/injury?
3.- Other (Please Comment)
OTHER: Other issues to
consider
1.2.Would you recommend that Mayo continues to use this product?

YES _____
NO ______

Comments:

Thank You for Completing This Form
If any questions arise, please e-mail Ben Hickox, APRN, CNS, D.N.P. at
Hickox.Benjamin@mayo.edu, Sam Porcher, RN at Porcher.Samantha@mayo.edu, or Cole
Gatzke, RN, at Gatzke.Cole@mayo.edu.
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Appendix H
Mayo IRB Wizard Memo

Date:

6/30/2022

From:

Mayo Clinic Institutional Review Board

Re:

Deep Sternal Wound Infection Prevention, Posthorax support vest implementation

To:

Samantha Porcher & Cole Gatzke

The Mayo Clinic Institutional Review Board (IRB) acknowledges that based on the responses
submitted for this new activity through the Mayo Clinic Quality Improvement Wizard tool, and
in accordance with the Code of Federal Regulations, 45 CFR 46.102, the above noted activity
does not require IRB review.
Other Federal, State and local laws and/or regulations may apply to the activity. This activity
may be reconsidered for submission to the IRB if any changes are made.
The Project Leader is responsible for the accuracy and reliability of the information submitted
through the Quality Improvement Wizard tool, for following all applicable Federal, State and
local laws and/or regulations, and is also responsible for submitting research studies to the IRB
when required.

Retain either a paper or electronic copy for your records.
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Your responses to the Quality Improvement Wizard, listed below, indicate that the project is a
Quality Improvement activity not requiring IRB review.
1. Does the project involve the prospective evaluation of a drug, device or clinical
procedure that is not currently approved by the FDA for general use (including "offlabel" indications)? NO
2. Has the project received funding (e.g. federal, industry) to be conducted as a human
subjects research study? NO
3. Will any project activities take place outside of Mayo Clinic? NO
4. Does the project involve prospective assignment of patients to different procedures or
therapies based on a predetermined plan such as randomization? NO
5. Will the project occur regardless of whether individuals conducting it may benefit
professionally from it? (If you couldn’t publish would you still do it?) YES
6. Is this project designed with the intent to contribute to generalizable knowledge? In other
words, is the primary intent to contribute to the field of study and benefit other researchers?
NO
7. Is the primary intent of the project to specifically improve an institutional process with the
intent of the conclusions to be most directly applicable to Mayo Clinic? YES
5. Will patients or personnel be exposed to additional discernible risks or burdens beyond
those of standard of care? NO
Should you have questions regarding the outcome of this submission, please contact the IRB
Knowledge and Navigation through the Research Service Center at 6-4000
Mayo Quality Academy provides quality improvement education across the enterprise.
Resources for publication of quality improvement projects may be found at:
Office of QI Scholarship >> SQUIRE (Standards for Quality Improvement Reporting
Excellence)
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Appendix I
Staff Informational Flyer

Coming this fall:

Posthoraxä Sternum Support Vest
What is it? A vest worn by median sternotomy patients at risk for
sternal wound infections from as early as post-op day 0 until 6 weeks
postop

Benefits:
•
•
•
•

prevents sternal wound infections
reduces pain after surgery
improves bone healing
increased ease of use of incentive spirometer and coughing and
deep breathing

More information to come!

